{"content":"<li class=\"n-box-item date-title\" data-end=\"1555041599\" data-start=\"1554955200\" data-txt=\"Monday, December 23, 2019\">Thursday, April 11, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3450192\" data-ts=\"1555021377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRS\" target=\"_blank\">AMRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450192-amyris-resumes-down-23_5-after-filing-on-credit-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amyris resumes down 23.5% after filing on credit agreement</a></h4><ul>   <li>Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) has resumed trading after a postmarket halt, <font color=\"red\">down 23.5%</font> after hours.</li>    <li>That follows a <a href=\"https://seekingalpha.com/filing/4442559\" target=\"_blank\">filing</a> where it notes entering into a credit agreement with Foris Ventures for $8M, which it borrowed in full on Monday. That note matures Oct. 14 of this year.</li>    <li>Foris is affiliated with director John Doerr of Kleiner Perkins Caufield &amp; Byers, an owner of more than a 5% stake.</li>    <li>The company agreed to pay Foris a fee of $1M, which will be reduced to $0.5M if the note's repaid in full by July 15.</li>    <li>Amyris also said that due to restatements, it expects revenue for fiscal 2018 will be reduced by $12M-$16M, and net income by $7M-$11M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3450192\" data-linked=\"Amyris resumes down 23.5% after filing on credit agreement\" data-tweet=\"$AMRS - Amyris resumes down 23.5% after filing on credit agreement https://seekingalpha.com/news/3450192-amyris-resumes-down-23_5-after-filing-on-credit-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3450192-amyris-resumes-down-23_5-after-filing-on-credit-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450189\" data-ts=\"1555020014\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XFOR\" target=\"_blank\">XFOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450189-x4-pharmaceuticalsminus-25_5-on-reported-80m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">X4 Pharmaceuticals -25.5% on reported $80M share offering</a></h4><ul>   <li>X4 Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/XFOR' title='X4 Pharmaceuticals, Inc.'>XFOR</a>) has <font color=\"red\">tumbled 25.5%</font> after hours on announcing a proposed public offering of common stock and warrants.</li>    <li>The company's said to offer $80M worth of shares at $11 each, Bloomberg says. Shares had closed at $15.10 today (<font color=\"red\">down 8.5%</font> during the regular session), and are quoted now at $11.25.</li>    <li>That offering if it comes will come via Cowen and Stifel.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3450189\" data-linked=\"X4 Pharmaceuticals -25.5% on reported $80M share offering\" data-tweet=\"$XFOR - X4 Pharmaceuticals -25.5% on reported $80M share offering https://seekingalpha.com/news/3450189-x4-pharmaceuticalsminus-25_5-on-reported-80m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3450189-x4-pharmaceuticalsminus-25_5-on-reported-80m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450187\" data-ts=\"1555019200\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450187-hchc-cvgi-ryi-and-hbb-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HCHC, CVGI, RYI and HBB among notable after hour movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/AQST' title='Aquestive Therapeutics, Inc.'>AQST</a> <font color=\"green\">+9.5%</font>. <a href='https://seekingalpha.com/symbol/ARA' title='American Renal Associates Holdings, Inc.'>ARA</a> <font color=\"green\">+7.4%</font>. <a href='https://seekingalpha.com/symbol/HCHC' title='HC2 Holdings, Inc.'>HCHC</a> <font color=\"green\">+5%</font>. <a href='https://seekingalpha.com/symbol/CYCN' title='Cyclerion Therapeutics, Inc.'>CYCN</a> <font color=\"green\">+4.7%</font>. <a href='https://seekingalpha.com/symbol/RYI' title='Ryerson Holding Corporation'>RYI</a> <font color=\"green\">+3.3%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/HBB' title='Hamilton Beach Brands Holding Company'>HBB</a> <font color=\"red\">-5.6%</font>. <a href='https://seekingalpha.com/symbol/CVGI' title='Commercial Vehicle Group, Inc.'>CVGI</a> <font color=\"red\">-4.8%</font>. <a href='https://seekingalpha.com/symbol/RBB' title='RBB Bancorp'>RBB</a> <font color=\"red\">-4.8%</font>. <a href='https://seekingalpha.com/symbol/HOFT' title='Hooker Furniture Corporation'>HOFT</a> <font color=\"red\">-3.5%</font>. <a href='https://seekingalpha.com/symbol/FSTR' title='L.B. Foster Company'>FSTR</a> <font color=\"red\">-3.4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450187\" data-linked=\"HCHC, CVGI, RYI and HBB among notable after hour movers\" data-tweet=\"$AQST $ARA $HCHC - HCHC, CVGI, RYI and HBB among notable after hour movers https://seekingalpha.com/news/3450187-hchc-cvgi-ryi-and-hbb-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3450187-hchc-cvgi-ryi-and-hbb-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450180\" data-ts=\"1555017526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATI\" target=\"_blank\">ATI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450180-allegheny-tech-sees-q1-earnings-below-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allegheny Tech sees Q1 earnings below consensus</a></h4><ul><li>Allegheny Technologies (NYSE:<a href='https://seekingalpha.com/symbol/ATI' title='Allegheny Technologies Incorporated'>ATI</a>) <font color=\"red\">-3.6%</font> after-hours as it expects <a href=\"https://seekingalpha.com/pr/17474755-ati-provides-update-first-quarter-2019-financial-results\" target=\"_blank\">Q1 EPS of $0.10-$0.13</a>, well below the $0.25 analyst consensus estimate, on revenues of $1B, in-line with consensus.</li><li>In its High Performance Materials and Components segment, ATI cites a greater than anticipated negative impact from the continued disruption in third party nickel powder billet supply, as well as higher operating costs.</li><li>In ATI\u2019s Flat Rolled Products segment, the STAL joint venture experienced lower than anticipated demand in China, including continued softness in the high-end consumer electronics market.</li><li>For both segments, ATI believes the negatives will       be reduced in Q2 and will not affect company       performance in H2 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450180\" data-linked=\"Allegheny Tech sees Q1 earnings below consensus\" data-tweet=\"$ATI - Allegheny Tech sees Q1 earnings below consensus https://seekingalpha.com/news/3450180-allegheny-tech-sees-q1-earnings-below-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3450180-allegheny-tech-sees-q1-earnings-below-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450176\" data-ts=\"1555016658\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UPWK\" target=\"_blank\">UPWK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450176-upworkplus-1_3-on-buy-start\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Upwork +1.3% on Buy start</a></h4><ul><li>BTIG starts Upwork (NASDAQ:<a href='https://seekingalpha.com/symbol/UPWK' title='Upwork Inc.'>UPWK</a>) at Buy with a $24 price target, implying a 22% upside.</li><li>Upwork is expected to report earnings on May 23. Analysts <a href=\"https://seekingalpha.com/symbol/UPWK/earnings\" target=\"_blank\">estimate</a> $68.83M in revenue and a $0.03 loss per share.</li><li>UPWK shares are <font color=\"green\">up 1.3%</font> after hours to $19.90.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450176\" data-linked=\"Upwork +1.3% on Buy start\" data-tweet=\"$UPWK - Upwork +1.3% on Buy start https://seekingalpha.com/news/3450176-upworkplus-1_3-on-buy-start?source=tweet\" data-url=\"https://seekingalpha.com/news/3450176-upworkplus-1_3-on-buy-start\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450170\" data-ts=\"1555016287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450170-entravision-stations-back-on-dish-network-after-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Entravision stations back on Dish Network after deal</a></h4><ul>   <li>After nine months away, Entravision's (NYSE:<a href='https://seekingalpha.com/symbol/EVC' title='Entravision Communications Corporation'>EVC</a>) stations have <a href=\"https://seekingalpha.com/pr/17474715-entravisions-univision-unimas-affiliated-television-stations-return-dish-network\" target=\"_blank\">returned to the air</a> on Dish Network (NASDAQ:<a href='https://seekingalpha.com/symbol/DISH' title='DISH Network Corporation'>DISH</a>).</li>    <li>The Univision and UniMas affiliated stations are available to Dish customers again in conjunction with the new carriage agreement between the two.</li>    <li>Entravision operates the stations in 24 markets.</li>    <li><a href='https://seekingalpha.com/symbol/EVC' title='Entravision Communications Corporation'>EVC</a> is <font color=\"green\">up 3.2%</font> after hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3450170\" data-linked=\"Entravision stations back on Dish Network after deal\" data-tweet=\"$EVC $DISH - Entravision stations back on Dish Network after deal https://seekingalpha.com/news/3450170-entravision-stations-back-on-dish-network-after-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3450170-entravision-stations-back-on-dish-network-after-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450164\" data-ts=\"1555015648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMPH\" target=\"_blank\">KMPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450164-kempharm-up-15-after-hours-kp415-nda-nears-finish-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KemPharm up 15% after hours as KP415 NDA nears finish line</a></h4><ul><li>KemPharm (NASDAQ:<a href='https://seekingalpha.com/symbol/KMPH' title='KemPharm, Inc.'>KMPH</a>) is up <font color=\"green\">15%</font> after hours in response to its <a href=\"https://seekingalpha.com/pr/17474674-kempharm-completes-kp415-pre-nda-meeting-fda\" target=\"_blank\">announcement</a> that it plans to file a U.S. marketing application later this quarter or in early Q3 seeking approval for KP415 for the treatment of attention deficit hyperactivity disorder &#40;ADHD&#41;.</li><li>The company recently met with the FDA to discuss the requirements for a New Drug Application &#40;NDA&#41; and the agency said the data package would be sufficient to support a filing.</li><li>Management will host a conference call today at 5:00 pm ET to discuss its plans.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450164\" data-linked=\"KemPharm up 15% after hours as KP415 NDA nears finish line\" data-tweet=\"$KMPH - KemPharm up 15% after hours as KP415 NDA nears finish line https://seekingalpha.com/news/3450164-kempharm-up-15-after-hours-kp415-nda-nears-finish-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3450164-kempharm-up-15-after-hours-kp415-nda-nears-finish-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450149\" data-ts=\"1555014010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRNX\" target=\"_blank\">TRNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450149-taronis-technologies-beats-12_93-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taronis Technologies beats by $12.93, misses on revenue</a></h4><ul><li>Taronis Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TRNX' title='Taronis Technologies, Inc.'>TRNX</a>): FY GAAP EPS of -$6.87 <span style=\"color:green\">beats by $12.93</span>.</li><li>Revenue of $9.71M (+161.0% Y/Y) <font color=\"red\">misses by $0.18M</font>.</li><li>Shares <font color=\"green\">+7.37%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17474600-taronis-generates-record-9_7-million-revenue-2018\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3450149\" data-linked=\"Taronis Technologies beats by $12.93, misses on revenue\" data-tweet=\"$TRNX - Taronis Technologies beats by $12.93, misses on revenue https://seekingalpha.com/news/3450149-taronis-technologies-beats-12_93-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3450149-taronis-technologies-beats-12_93-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450148\" data-ts=\"1555013983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPHT\" target=\"_blank\">OPHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450148-ophthotech-in-licenses-gene-therapies-for-type-of-macular-degeneration-shares-up-29-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ophthotech in-licenses gene therapies for type of macular degeneration; shares up 29% after hours</a></h4><ul><li>Thinly traded nano cap Ophthotech (NASDAQ:<a href='https://seekingalpha.com/symbol/OPHT' title='Ophthotech Corporation'>OPHT</a>) is up <font color=\"green\">29%</font> after hours in response to its <a href=\"https://seekingalpha.com/pr/17474609-ophthotech-obtains-exclusive-global-license-aav-gene-therapy-program-best1-related-retinal\" target=\"_blank\">in-licensing deal</a> for adeno-associated virus &#40;AAV&#41; gene therapy candidates for Best vitelliform macular dystrophy, an inherited form of macular degeneration related to mutations in a gene called BEST1.</li><li>A Phase 1/2 clinical trial should commence in H2 2021.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450148\" data-linked=\"Ophthotech in-licenses gene therapies for type of macular degeneration; shares up 29% after hours\" data-tweet=\"$OPHT $ISEE - Ophthotech in-licenses gene therapies for type of macular degeneration; shares up 29% after hours https://seekingalpha.com/news/3450148-ophthotech-in-licenses-gene-therapies-for-type-of-macular-degeneration-shares-up-29-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3450148-ophthotech-in-licenses-gene-therapies-for-type-of-macular-degeneration-shares-up-29-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450139\" data-ts=\"1555013336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XFOR\" target=\"_blank\">XFOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450139-x4-pharma-launches-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">X4 Pharma launches equity offering</a></h4><ul><li>X4 Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/XFOR' title='X4 Pharmaceuticals, Inc.'>XFOR</a>) commences a public offering of common stock and warrants. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450139\" data-linked=\"X4 Pharma launches equity offering\" data-tweet=\"$XFOR - X4 Pharma launches equity offering https://seekingalpha.com/news/3450139-x4-pharma-launches-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3450139-x4-pharma-launches-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450133\" data-ts=\"1555012866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AON\" target=\"_blank\">AON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450133-aon-rebounds-after-report-of-probe-over-fired-employee\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aon rebounds after report of probe over fired employee</a></h4><ul><li>Two federal agencies <a href=\"https://insuranceinsider.com/articles/125787/aon-facing-nlrb-and-eeoc-probes-of-termination-claim\" target=\"_blank\">are investigating</a> allegations that Aon (<a href='https://seekingalpha.com/symbol/AON' title='Aon plc'>AON</a> <font color='green'>+0.6%</font>) fired an employee in retaliation for complaining about sexual harassment, <em>Insurance Insider</em> reports.</li><li>Aon disputed the claims, saying the employee was dismissed for \"speaking disparagingly\" about the company to clients.</li><li>Aon shares had fallen as much as 5.5% after the report, but have since bounced back.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450133\" data-linked=\"Aon rebounds after report of probe over fired employee\" data-tweet=\"$AON - Aon rebounds after report of probe over fired employee https://seekingalpha.com/news/3450133-aon-rebounds-after-report-of-probe-over-fired-employee?source=tweet\" data-url=\"https://seekingalpha.com/news/3450133-aon-rebounds-after-report-of-probe-over-fired-employee\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450128\" data-ts=\"1555011844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPVD\" target=\"_blank\">MPVD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450128-mountain-province-reports-74-hike-in-faraday-diamond-resource\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mountain Province reports 74% hike in Faraday diamond resource</a></h4><ul><li>Mountain Province Diamonds (<a href='https://seekingalpha.com/symbol/MPVD' title='Mountain Province Diamonds Inc.'>MPVD</a> <font color='green'>+8.7%</font>) spikes higher after saying the year-end 2018 updated inferred mineral resource at its Faraday 2 project in Canada <a href=\"http://www.mining.com/mountain-province-stock-takes-off-74-diamond-resource-increase/\" target=\"_blank\">surged 74% Y/Y</a> to 5.45M carats of diamonds vs. its 2017 estimate  of 3.13M carats.</li><li>MPVD also reports a total of 2.07m metric tons of  kimberlite at the project, 49% above the previous estimate, with an overall grade of 2.63 carats/mt vs. 2.24 carats/mt in 2017.</li><li>MPVD says the attributed average value at Faraday 2 has  increased to $140/carat, up 25% from the 2017 value of $112/carat.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450128\" data-linked=\"Mountain Province reports 74% hike in Faraday diamond resource\" data-tweet=\"$MPVD - Mountain Province reports 74% hike in Faraday diamond resource https://seekingalpha.com/news/3450128-mountain-province-reports-74-hike-in-faraday-diamond-resource?source=tweet\" data-url=\"https://seekingalpha.com/news/3450128-mountain-province-reports-74-hike-in-faraday-diamond-resource\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450118\" data-ts=\"1555009244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNPS\" target=\"_blank\">SNPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450118-rbc-boosts-synopsys-to-street-high-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC boosts Synopsys to Street-high target</a></h4><ul><li>RBC raises its Synopsys (NASDAQ:<a href='https://seekingalpha.com/symbol/SNPS' title='Synopsys, Inc.'>SNPS</a>) price target from $130 to $140.</li><li>Synopsys is expected to report earnings on May 22. Analysts <a href=\"https://seekingalpha.com/symbol/SNPS/earnings\" target=\"_blank\">estimate</a> $829.33M in revenue with $1.09 EPS.</li><li>Synopsys shares are <font color=\"green\">up 0.7%</font> to $118.14.</li><li>Update with more details from the analyst note:</li><li>Mitch Steves reiterates his top pick call and sees long-term upside to $6.50 EPS (was $6).</li><li>Steves cites higher conviction in margin expansion due to rising SoC costs and thinks the software integrity business will remain profitable.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450118\" data-linked=\"RBC boosts Synopsys to Street-high target\" data-tweet=\"$SNPS - RBC boosts Synopsys to Street-high target https://seekingalpha.com/news/3450118-rbc-boosts-synopsys-to-street-high-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3450118-rbc-boosts-synopsys-to-street-high-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450117\" data-ts=\"1555009183\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQM\" target=\"_blank\">SQM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450117-tianqi-signs-deal-in-governance-of-chilean-lithium-miner-sqm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tianqi signs deal in governance of Chilean lithium miner SQM</a></h4><ul><li>China\u2019s Tianqi Lithium reaches an <a href=\"https://www.reuters.com/article/us-sqm-tianqi-lithium/chinas-tianqi-agrees-truce-in-battle-over-chilean-lithium-miner-sqm-idUSKCN1RN2B0\" target=\"_blank\">agreement related to the governance</a> of Sociedad Quimica y Minera (<a href='https://seekingalpha.com/symbol/SQM' title='Sociedad Química y Minera de Chile S.A.'>SQM</a> <font color='red'>-1.9%</font>) with shareholder Pampa Group, pulling back from conflict over the control of the Chilean lithium producer.</li><li>The agreement established that SQM board decisions and the company\u2019s operations would be independent of both parties.</li><li>The $4.1B purchase of a 23.77% stake in SQM was approved in December but Pampa had tried to block the transaction, raising concerns that the move would allow the Chinese firm to access strategic information from the miner.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450117\" data-linked=\"Tianqi signs deal in governance of Chilean lithium miner SQM\" data-tweet=\"$SQM - Tianqi signs deal in governance of Chilean lithium miner SQM https://seekingalpha.com/news/3450117-tianqi-signs-deal-in-governance-of-chilean-lithium-miner-sqm?source=tweet\" data-url=\"https://seekingalpha.com/news/3450117-tianqi-signs-deal-in-governance-of-chilean-lithium-miner-sqm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450115\" data-ts=\"1555009143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450115-technology-movers-phunware-leads-gainers-while-semileds-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology movers: Phunware leads gainers, while SemiLEDs leads the losers</a></h4><ul><li><strong>Gainers: </strong>Phunware (NASDAQ:<a href='https://seekingalpha.com/symbol/PHUN' title='Phunware Inc.'>PHUN</a>) <font color=\"green\">+57%</font>. UP Fintech Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TIGR' title='UP Fintech Holding Limited'>TIGR</a>) <font color=\"green\">+10%</font>. Creative Realities (NASDAQ:<a href='https://seekingalpha.com/symbol/CREX' title='Creative Realities, Inc.'>CREX</a>) <font color=\"green\">+9%</font>. Airgain (NASDAQ:<a href='https://seekingalpha.com/symbol/AIRG' title='Airgain, Inc.'>AIRG</a>) <font color=\"green\">+10%</font>. Aurora Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/JG' title='Aurora Mobile Limited'>JG</a>) <font color=\"green\">+9%</font>.</li> <li><strong>Losers: </strong>SemiLEDs (NASDAQ:<a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a>) <font color=\"red\">-19%</font>. Inpixon (NASDAQ:<a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a>) <font color=\"red\">-11%</font>. MACOM Technology Solutions Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MTSI' title='MACOM Technology Solutions Holdings, Inc.'>MTSI</a>) <font color=\"red\">-11%</font>. B.O.S Better Online Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/BOSC' title='B.O.S Better Online Solutions Ltd.'>BOSC</a>) <font color=\"red\">-10%</font>. Safe-T Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd'>SFET</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3450115\" data-linked=\"Technology movers: Phunware leads gainers, while SemiLEDs leads the losers\" data-tweet=\"$TIGR $CREX $AIRG - Technology movers: Phunware leads gainers, while SemiLEDs leads the losers https://seekingalpha.com/news/3450115-technology-movers-phunware-leads-gainers-while-semileds-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3450115-technology-movers-phunware-leads-gainers-while-semileds-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450111\" data-ts=\"1555008884\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTCH\" target=\"_blank\">MTCH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450111-tinder-becomes-top-non-game-app\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tinder becomes top non-game app</a></h4><ul><li>Tinder (NASDAQ:<a href='https://seekingalpha.com/symbol/MTCH' title='Match Group, Inc.'>MTCH</a>) snatches the Q1 top spot from Netflix, which held the top-earner title since Q4 2016, according to both Sensor Tower and App Annie estimates.</li><li>In December, Netflix stopped allowing users to sign up and subscribe through its iOS app to get around paying a cut to Apple.</li><li>Tencent (<a href='https://seekingalpha.com/symbol/TCEHY' title='Tencent Holdings Limited'>OTCPK:TCEHY</a>) Video took the number three spot, iQIYI (<a href='https://seekingalpha.com/symbol/IQ' title='iQIYI, Inc.'>IQ</a> <font color='red'>-3.8%</font>) followed, and YouTube rounded out the top five.</li><li>Match Group shares are <font color=\"green\">up 1.25%</font> to $57.70.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450111\" data-linked=\"Tinder becomes top non-game app\" data-tweet=\"$MTCH $MTCH $TCEHY - Tinder becomes top non-game app https://seekingalpha.com/news/3450111-tinder-becomes-top-non-game-app?source=tweet\" data-url=\"https://seekingalpha.com/news/3450111-tinder-becomes-top-non-game-app\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450108\" data-ts=\"1555007709\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBAY\" target=\"_blank\">EBAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450108-ebay-ceo-fires-back-bezos\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EBay CEO fires back at Bezos</a></h4><ul><li>EBay (<a href='https://seekingalpha.com/symbol/EBAY' title='eBay Inc.'>EBAY</a> <font color='red'>-4.7%</font>) CEO Devin Wenig takes to Twitter to respond to what's being considered something of a shot by Jeff Bezos in his annual letter to shareholders when he compared 20-year third-party seller growth sales on the two platforms (AMZN +52% vs. EBAY +20%).</li><li>\"While I appreciate the ink dedicated to @ebay from the ceo of the company not focused on competition, think I\u201dll dedicate my letter to customers, purpose and strategy.  We don\u2019t compete with our sellers.  We don\u2019t bundle endless services to create barriers to competition,\" tweets Wenig.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450108\" data-linked=\"EBay CEO fires back at Bezos\" data-tweet=\"$EBAY - EBay CEO fires back at Bezos https://seekingalpha.com/news/3450108-ebay-ceo-fires-back-bezos?source=tweet\" data-url=\"https://seekingalpha.com/news/3450108-ebay-ceo-fires-back-bezos\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450105\" data-ts=\"1555007217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CJJD\" target=\"_blank\">CJJD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450105-china-jo-jo-down-43-on-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Jo-Jo down 43% on equity offering</a></h4><ul><li>China Jo-Jo Drugstores (<a href='https://seekingalpha.com/symbol/CJJD' title='China Jo-Jo Drugstores, Inc.'>CJJD</a> <font color=\"red\">-43.4%</font>) slumps on a 4x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/17474035-china-jo-jo-drugstores-announces-10-million-registered-direct-offering\" target=\"_blank\">direct placement</a> of ~4M common shares at $2.50 per share to institutional investors who will also receive unregistered warrants to purchase up to ~3M shares.</li><li>Closing date is April 15.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450105\" data-linked=\"China Jo-Jo down 43% on equity offering\" data-tweet=\"$CJJD - China Jo-Jo down 43% on equity offering https://seekingalpha.com/news/3450105-china-jo-jo-down-43-on-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3450105-china-jo-jo-down-43-on-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450106\" data-ts=\"1555007176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FAST\" target=\"_blank\">FAST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450106-fastenal-jumps-to-all-time-highs-following-q1-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fastenal jumps to all-time highs following Q1 report</a></h4><ul><li>Fastenal (<a href='https://seekingalpha.com/symbol/FAST' title='Fastenal Company'>FAST</a> <font color=\"green\">+4.6%</font>) is surging after its <a href=\"https://seekingalpha.com/news/3449882-fastenal-beats-0_01-revenue-line\" target=\"_blank\">narrow Q1 earnings beat</a>, but <a href=\"https://www.briefing.com/investor/analysis/story-stocks/fastenal-jumps-to-alltime-highs-following-solid-q1-report-%28fast%29.htm\" target=\"_blank\">investors are focusing</a> on the company\u2019s stabilizing gross margin and improving operating margin.</li><li>FAST reported gross margin slipped to 47.7% from 48.8% in the year-ago  quarter but analysts think the downtrend may have run its course, and operating margin rose 20 bps Y/Y to 20%, indicating an effective effort in managing costs.</li><li>Demand also remains healthy, as FAST delivered its eighth straight  quarter of double-digit revenue growth; for Q1, net sales increased ~10% to $1.31B, in line with expectations.</li><li>Wells Fargo's Allison Polinak says FAST's March sales <a href=\"https://www.barrons.com/articles/fastenal-s-p-500-best-stock-earnings-good-news-about-the-economy-51554998242\" target=\"_blank\">ended the quarter on a positive note</a>, and \"importantly... the spread between national account and non-national account growth narrowed to 11% vs. 13% previously. We view this as a positive indicator for the macro environment,\" showing that small businesses are growing as much as FAST's large multinational customers.</li><li>FAST has exposure to many cyclical, economically-sensitive industries such as construction, original  equipment manufacturers, railroads, oil and gas, and transportation, and 85% of its business is generated from the U.S.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLI' title='Industrial Select Sector SPDR ETF'>XLI</a>, <a href='https://seekingalpha.com/symbol/VIS' title='Vanguard Industrials ETF'>VIS</a>, <a href='https://seekingalpha.com/symbol/FIDU' title='Fidelity MSCI Industrials Index ETF'>FIDU</a>, <a href='https://seekingalpha.com/symbol/IFLY' title='ETFMG Drone Economy Strategy ETF'>IFLY</a>, <a href='https://seekingalpha.com/symbol/IYJ' title='iShares U.S. Industrials ETF'>IYJ</a>, <a href='https://seekingalpha.com/symbol/FXR' title='First Trust Industrials AlphaDEX ETF'>FXR</a>, <a href='https://seekingalpha.com/symbol/AIRR' title='First Trust RBA American Industrial Renaissance ETF'>AIRR</a>, <a href='https://seekingalpha.com/symbol/RGI' title='Invesco S&P Equal Weight Industrial ETF'>RGI</a>, <a href='https://seekingalpha.com/symbol/UXI' title='ProShares Ultra Industrials ETF'>UXI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3450106\" data-linked=\"Fastenal jumps to all-time highs following Q1 report\" data-tweet=\"$FAST $XLI $VIS - Fastenal jumps to all-time highs following Q1 report https://seekingalpha.com/news/3450106-fastenal-jumps-to-all-time-highs-following-q1-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3450106-fastenal-jumps-to-all-time-highs-following-q1-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450103\" data-ts=\"1555006866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMRN\" target=\"_blank\">IMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450103-immuron-nabs-u-s-patent-for-c-diff-treatment-shares-up-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immuron nabs U.S. patent for C. diff treatment; shares up 16%</a></h4><ul><li>Ultra-thinly traded Immuron (<a href='https://seekingalpha.com/symbol/IMRN' title='Immuron Limited'>IMRN</a> <font color=\"green\">+15.5%</font>) is up on a 29x surge in volume, albeit on turnover of only 55K shares, in response to the issuance of a new <a href=\"https://seekingalpha.com/pr/17474137-immuron-receives-u-s-patent-drug-composition-treat-clostridium-difficile\" target=\"_blank\">U.S. patent</a> covering a method to treat <em>Clostridium difficile</em> (<em>C. diff</em>) infections.</li><li>The method, describing a targeted drug composition of an enriched hyperimmune polyclonal antibody preparation of bovine colostrum, applies to pipeline candidate IMM-529, currently in Phase 1/2a development.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450103\" data-linked=\"Immuron nabs U.S. patent for C. diff treatment; shares up 16%\" data-tweet=\"$IMRN - Immuron nabs U.S. patent for C. diff treatment; shares up 16% https://seekingalpha.com/news/3450103-immuron-nabs-u-s-patent-for-c-diff-treatment-shares-up-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3450103-immuron-nabs-u-s-patent-for-c-diff-treatment-shares-up-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450098\" data-ts=\"1555006052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNCE\" target=\"_blank\">VNCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450098-post-earnings-slide-for-vince-holdings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings slide for Vince Holdings</a></h4><ul><li>Vince Holdings (<a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='red'>-10.6%</font>) falls on a move that could be tied to a comment made by CEO Brendan Hoffman on the retailer's \"slow start\" to Q1.</li><li>Later in the call, CFO Dave Stefko clarified that the softness was tied to the direct-to-consumer business during the month of February, and improved trends were seen in March.</li><li><a href=\"https://seekingalpha.com/article/4253866-vince-holding-corp-s-vnce-ceo-brendan-hoffman-q4-2018-results-earnings-call-transcript\" target=\"_blank\">Vince Holdings earnings call transcript</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3450098\" data-linked=\"Post-earnings slide for Vince Holdings\" data-tweet=\"$VNCE - Post-earnings slide for Vince Holdings https://seekingalpha.com/news/3450098-post-earnings-slide-for-vince-holdings?source=tweet\" data-url=\"https://seekingalpha.com/news/3450098-post-earnings-slide-for-vince-holdings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450096\" data-ts=\"1555005843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACER\" target=\"_blank\">ACER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450096-acer-therapeutics-breaks-out-of-consolidation-up-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acer Therapeutics breaks out of consolidation, up 12%</a></h4><ul><li>Thinly traded micro cap Acer Therapeutics (<a href='https://seekingalpha.com/symbol/ACER' title='Acer Therapeutics Inc.'>ACER</a> <font color=\"green\">+12.1%</font>) clears a 13-week base on more than a 4x surge in volume, albeit on turnover of only 133K shares.</li><li>No particular news accounts for the breakout, but a key upcoming catalyst is the FDA's June 25 action date for its review of the company's marketing application seeking approval for <a href=\"https://acertx.com/rare-disease-research/edsivo-celiprolol-for-veds/\" target=\"_blank\">EDSIVO </a>(celiprolol) for the treatment of an inherited collagen disorder called vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation, a disease with no effective treatments affecting ~5K Americans.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450096\" data-linked=\"Acer Therapeutics breaks out of consolidation, up 12%\" data-tweet=\"$ACER - Acer Therapeutics breaks out of consolidation, up 12% https://seekingalpha.com/news/3450096-acer-therapeutics-breaks-out-of-consolidation-up-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3450096-acer-therapeutics-breaks-out-of-consolidation-up-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450094\" data-ts=\"1555005585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450094-zk-international-group-and-torchlight-energy-resources-among-energy-materials-gainers-amyris\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ZK International Group and Torchlight Energy Resources among Energy/Materials gainers; Amyris and BP Prudhoe Bay Royalty Trust among losers</a></h4><ul><li><b>Gainers: </b>ZK International Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ZKIN' title='ZK International Group Co., Ltd.'>ZKIN</a>) <font color=\"green\">+13%</font>. Torchlight Energy Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/TRCH' title='Torchlight Energy Resources, Inc.'>TRCH</a>) <font color=\"green\">+12%</font>. Ossen Innovation (NASDAQ:<a href='https://seekingalpha.com/symbol/OSN' title='Ossen Innovation Co., Ltd.'>OSN</a>) <font color=\"green\">+10%</font>. Gulf Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/GURE' title='Gulf Resources, Inc.'>GURE</a>) <font color=\"green\">+10%</font>. Chaparral Energy (NYSE:<a href='https://seekingalpha.com/symbol/CHAP' title='Chaparral Energy, Inc.'>CHAP</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"red\">-22%</font>. BP Prudhoe Bay Royalty Trust (NYSE:<a href='https://seekingalpha.com/symbol/BPT' title='BP Prudhoe Bay Royalty Trust'>BPT</a>) <font color=\"red\">-10%</font>. Platinum Group Metals (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLG' title='Platinum Group Metals Ltd.'>PLG</a>) <font color=\"red\">-10%</font>. Lilis Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LLEX' title='Lilis Energy, Inc.'>LLEX</a>) <font color=\"red\">-8%</font>. AK Steel (NYSE:<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corporation'>AKS</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450094\" data-linked=\"ZK International Group and Torchlight Energy Resources among Energy/Materials gainers; Amyris and BP Prudhoe Bay Royalty Trust among losers\" data-tweet=\"$ZKIN $TRCH $OSN - ZK International Group and Torchlight Energy Resources among Energy/Materials gainers; Amyris and BP Prudhoe Bay Royalty Trust among losers https://seekingalpha.com/news/3450094-zk-international-group-and-torchlight-energy-resources-among-energy-materials-gainers-amyris?source=tweet\" data-url=\"https://seekingalpha.com/news/3450094-zk-international-group-and-torchlight-energy-resources-among-energy-materials-gainers-amyris\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450092\" data-ts=\"1555004593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNST\" target=\"_blank\">MNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450092-monster-beverage-on-watch-after-amazon-energy-drink-launch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monster Beverage on watch after Amazon energy drink launch</a></h4><ul><li>Monster Beverage (<a href='https://seekingalpha.com/symbol/MNST' title='Monster Beverage Corporation'>MNST</a> <font color='red'>-0.4%</font>) has been trading with volatility amid concerns over private-label energy drinks being sold by Amazon off its website.</li><li>TJI Research <a href=\"https://this.just.in/amazon-launches-private-label-energy-drinks/\" target=\"_blank\">reports</a> the new drinks are called Solimo Red Energy Drink and Solimo Silver Energy Drink. A pack of 24 16-ounce cans is priced at $29.99 for both products.</li><li>Shares of Monster were down over 4% earlier in the session before bouncing back.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450092\" data-linked=\"Monster Beverage on watch after Amazon energy drink launch\" data-tweet=\"$MNST - Monster Beverage on watch after Amazon energy drink launch https://seekingalpha.com/news/3450092-monster-beverage-on-watch-after-amazon-energy-drink-launch?source=tweet\" data-url=\"https://seekingalpha.com/news/3450092-monster-beverage-on-watch-after-amazon-energy-drink-launch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450086\" data-ts=\"1555002582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450086-china-bat-group-leads-financial-gainers-victory-capital-holdings-and-u-s-global-investors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Bat Group leads financial gainers; Victory Capital Holdings and U.S. Global Investors among losers</a></h4><ul><li><b>Gainers:</b> China Bat Group (NASDAQ:<a href='https://seekingalpha.com/symbol/GLG' title='China Bat Group, Inc.'>GLG</a>) <font color=\"green\">+59%</font>. Dragon Victory International (NASDAQ:<a href='https://seekingalpha.com/symbol/LYL' title='Dragon Victory International Limited'>LYL</a>) <font color=\"green\">+7%</font>. Yirendai (NYSE:<a href='https://seekingalpha.com/symbol/YRD' title='Yirendai Ltd.'>YRD</a>) <font color=\"green\">+7%</font>. Customers Bancorp (NYSE:<a href='https://seekingalpha.com/symbol/CUBI' title='Customers Bancorp, Inc.'>CUBI</a>) <font color=\"green\">+6%</font>. Yangtze River Port and Logistics (NASDAQ:<a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> Atlas Financial Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AFH' title='Atlas Financial Holdings, Inc.'>AFH</a>) <font color=\"red\">-8%</font>. Victory Capital Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/VCTR' title='Victory Capital Holdings, Inc.'>VCTR</a>) <font color=\"red\">-6%</font>. GAIN Capital Holdings (NYSE:<a href='https://seekingalpha.com/symbol/GCAP' title='GAIN Capital Holdings, Inc.'>GCAP</a>) <font color=\"red\">-5%</font>. U.S. Global Investors (NASDAQ:<a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450086\" data-linked=\"China Bat Group leads financial gainers; Victory Capital Holdings and U.S. Global Investors among losers\" data-tweet=\"$GLG $LYL $YRD - China Bat Group leads financial gainers; Victory Capital Holdings and U.S. Global Investors among losers https://seekingalpha.com/news/3450086-china-bat-group-leads-financial-gainers-victory-capital-holdings-and-u-s-global-investors?source=tweet\" data-url=\"https://seekingalpha.com/news/3450086-china-bat-group-leads-financial-gainers-victory-capital-holdings-and-u-s-global-investors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450082\" data-ts=\"1555002267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450082-sky-considers-phone-service-in-italy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sky considers phone service in Italy</a></h4><ul>   <li>Sky (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color=\"red\">-0.2%</font>) is reportedly planning to launch telephone services in Italy.</li>    <li>The company would launch service at the end of the summer after making a final decision in the next few weeks, <i>La Repubblica</i> reports.</li>    <li>And Sky is considering Maximo Ibarra, CEO of Royal KPN (<a href=\"http://seekingalpha.com/symbol/KKPNY\" target=\"_blank\">KKPNY</a> <font color=\"green\">+0.2%</font>), as a candidate to run the operation, according to the report. Other candidates include Fastweb chief Alberto Calcagno, and Pietro Scott Jovane, ex-chief commercial officer of Telecom Italia (<a href=\"http://seekingalpha.com/symbol/TI\" target=\"_blank\">TI</a> <font color=\"red\">-2.3%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3450082\" data-linked=\"Sky considers phone service in Italy\" data-tweet=\"$CMCSA $KKPNY $TI - Sky considers phone service in Italy https://seekingalpha.com/news/3450082-sky-considers-phone-service-in-italy?source=tweet\" data-url=\"https://seekingalpha.com/news/3450082-sky-considers-phone-service-in-italy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450080\" data-ts=\"1555002018\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450080-toughbuilt-industries-only-industrial-gainer-apogee-enterprises-and-mict-in-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ToughBuilt Industries only industrial gainer; Apogee Enterprises and MICT in losers</a></h4><ul><li><b>Gainers: </b>ToughBuilt Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/TBLT' title='ToughBuilt Industries, Inc.'>TBLT</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Apogee Enterprises (NASDAQ:<a href='https://seekingalpha.com/symbol/APOG' title='Apogee Enterprises, Inc.'>APOG</a>) <font color=\"red\">-7%</font>. MICT (NASDAQ:<a href='https://seekingalpha.com/symbol/MICT' title='MICT, Inc.'>MICT</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450080\" data-linked=\"ToughBuilt Industries only industrial gainer; Apogee Enterprises and MICT in losers\" data-tweet=\"$TBLT $APOG $MICT - ToughBuilt Industries only industrial gainer; Apogee Enterprises and MICT in losers https://seekingalpha.com/news/3450080-toughbuilt-industries-only-industrial-gainer-apogee-enterprises-and-mict-in-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3450080-toughbuilt-industries-only-industrial-gainer-apogee-enterprises-and-mict-in-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450078\" data-ts=\"1555001905\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICPT\" target=\"_blank\">ICPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450078-nash-players-in-red-easl-announcements-fail-to-excite-investors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NASH players in the red as EASL announcements fail to excite investors</a></h4><ul><li>Most developers of therapies to treat nonalcoholic steatohepatitis &#40;NASH&#41; are under modest pressure as investors remain unimpressed with the initial announcements from The International Liver Congress in Vienna.</li><li>Intercept Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals, Inc.'>ICPT</a> <font color=\"red\">-13.4%</font>) is leading the retreat after it <a href=\"https://seekingalpha.com/news/3449915-intercept-reports-additional-data-late-stage-study-oca-nash\" target=\"_blank\">reported </a>\"selected\" data from a late-stage study of obeticholic acid.</li><li>Related tickers: Gilead Sciences (<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color=\"red\">-1.7%</font>); Enanta Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ENTA' title='Enanta Pharmaceuticals, Inc.'>ENTA</a> <font color=\"red\">-2.4%</font>); Viking Therapeutics (<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics, Inc.'>VKTX</a> <font color=\"green\">+0.7%</font>); Madrigal Pharmaceuticals (<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a> <font color=\"red\">-8.3%</font>); CymaBay Therapeutics (<a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics, Inc.'>CBAY</a> <font color=\"red\">-0.8%</font>); Galectin Therapeutics (<a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color=\"red\">-4.6%</font>); Wave Life Sciences (<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences Ltd.'>WVE</a> <font color=\"red\">-0.2%</font>); Genfit (<a href='https://seekingalpha.com/symbol/GNFT' title='Genfit SA'>GNFT</a> <font color=\"red\">-0.5%</font>); Regeneron Pharmaceuticals (<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color=\"red\">-2.7%</font>); Alnylam Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color=\"red\">-2.9%</font>); Assembly Biosciences (<a href='https://seekingalpha.com/symbol/ASMB' title='Assembly Biosciences, Inc.'>ASMB</a> <font color=\"green\">+5.5%</font>); Can-Fite BioPharma (<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a> <font color=\"red\">-3.4%</font>); DURECT (<a href='https://seekingalpha.com/symbol/DRRX' title='DURECT Corporation'>DRRX</a> <font color=\"red\">-1.2%</font>); Galmed Pharmaceuticals (<a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color=\"green\">+1.1%</font>); Immuron (<a href='https://seekingalpha.com/symbol/IMRN' title='Immuron Limited'>IMRN</a> <font color=\"green\">+13.9%</font>); Gemphire Therapeutics (<a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics Inc.'>GEMP</a>); Conatus Pharmaceuticals (<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals Inc.'>CNAT</a> <font color=\"red\">-3.8%</font>); Arcturus Therapeutics (<a href='https://seekingalpha.com/symbol/ARCT' title='Arcturus Therapeutics Ltd.'>ARCT</a> <font color=\"red\">-0.9%</font>); Reata Pharmaceuticals (<a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals, Inc.'>RETA</a> <font color=\"red\">-1%</font>); FibroGen (<a href='https://seekingalpha.com/symbol/FGEN' title='FibroGen, Inc.'>FGEN</a> <font color=\"red\">-0.7%</font>); Innovate Biopharmaceuticals (<a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a> <font color=\"green\">+7.1%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3450078\" data-linked=\"NASH players in the red as EASL announcements fail to excite investors\" data-tweet=\"$ICPT $GILD $ENTA - NASH players in the red as EASL announcements fail to excite investors https://seekingalpha.com/news/3450078-nash-players-in-red-easl-announcements-fail-to-excite-investors?source=tweet\" data-url=\"https://seekingalpha.com/news/3450078-nash-players-in-red-easl-announcements-fail-to-excite-investors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450075\" data-ts=\"1555001459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450075-midday-movers-and-shakers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday movers and shakers</a></h4><ul><li><strong>Gainers:</strong> China Bat Group (NASDAQ:<a href='https://seekingalpha.com/symbol/GLG' title='China Bat Group, Inc.'>GLG</a>) <font color=\"green\">+66%</font>.  Papa Murphy's Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/FRSH' title='Papa Murphy&#39;s Holdings, Inc.'>FRSH</a>) <font color=\"green\">+31%</font>. Phunware (NASDAQ:<a href='https://seekingalpha.com/symbol/PHUN' title='Phunware Inc.'>PHUN</a>) <font color=\"green\">+22%</font>. Evofem Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/EVFM' title='Evofem Biosciences, Inc.'>EVFM</a>) <font color=\"green\">+18%</font>. American Renal Associates Holdings (NYSE:<a href='https://seekingalpha.com/symbol/ARA' title='American Renal Associates Holdings, Inc.'>ARA</a>) <font color=\"green\">+15%</font>. Acer Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ACER' title='Acer Therapeutics Inc.'>ACER</a>) <font color=\"green\">+14%</font>. ZK International Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ZKIN' title='ZK International Group Co., Ltd.'>ZKIN</a>) <font color=\"green\">+14%</font>. Immuron (NASDAQ:<a href='https://seekingalpha.com/symbol/IMRN' title='Immuron Limited'>IMRN</a>) <font color=\"green\">+14%</font>. The Alkaline Water Company (NASDAQ:<a href='https://seekingalpha.com/symbol/WTER' title='The Alkaline Water Company Inc.'>WTER</a>) <font color=\"green\">+11%</font>. Hancock Jaffe Laboratories (NASDAQ:<a href='https://seekingalpha.com/symbol/HJLI' title='Hancock Jaffe Laboratories, Inc.'>HJLI</a>) <font color=\"green\">+10%</font>.</li> <li><strong>Losers: </strong>China Jo-Jo Drugstores (NASDAQ:<a href='https://seekingalpha.com/symbol/CJJD' title='China Jo-Jo Drugstores, Inc.'>CJJD</a>) <font color=\"red\">-44%</font>. Farmmi (NASDAQ:<a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi, Inc.'>FAMI</a>) <font color=\"red\">-37%</font>. Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"red\">-21%</font>. ATA (NASDAQ:<a href='https://seekingalpha.com/symbol/ATAI' title='ATA Inc.'>ATAI</a>) <font color=\"red\">-20%</font>. SemiLEDs (NASDAQ:<a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a>) <font color=\"red\">-15%</font>. Marathon Patent Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>) <font color=\"red\">-14%</font>. Intercept Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals, Inc.'>ICPT</a>) <font color=\"red\">-14%</font>. Inpixon (NASDAQ:<a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a>) <font color=\"red\">-13%</font>. Four Seasons Education (NYSE:<a href='https://seekingalpha.com/symbol/FEDU' title='Four Seasons Education &#40;Cayman&#41; Inc.'>FEDU</a>) <font color=\"red\">-13%</font>. Weight Watchers International (NASDAQ:<a href='https://seekingalpha.com/symbol/WTW' title='Weight Watchers International, Inc.'>WTW</a>) <font color=\"red\">-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3450075\" data-linked=\"Midday movers and shakers\" data-tweet=\"$GLG $FRSH $EVFM - Midday movers and shakers https://seekingalpha.com/news/3450075-midday-movers-and-shakers?source=tweet\" data-url=\"https://seekingalpha.com/news/3450075-midday-movers-and-shakers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450068\" data-ts=\"1555000433\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXK\" target=\"_blank\">EXK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450068-endeavour-silverminus-5-q1-production-falls-sharply\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endeavour Silver -5% as Q1 production falls sharply</a></h4><ul><li>Endeavour Silver (<a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a> <font color=\"red\">-5.6%</font>) slides after reporting <a href=\"https://seekingalpha.com/pr/17473433-endeavour-silver-produces-1071-355-oz-silver-10055-oz-gold-1_9-million-oz-silver-equivalent\" target=\"_blank\">declining production</a> at its four mines in Mexico during Q1, resulting in 1.9M of silver equiv. oz.</li><li>EXK says silver output sank 21% Y/Y 1.07M oz. and gold production tumbled 24% to 10K oz. due to the planned reduction of mine output at El Cubo, lower than planned  throughput at Bolanitos and lower silver grades at Guanacevi.</li><li>\"All four mines typically start slowly each year as we commence our annual capital investments, then production improves as the  mines work toward achieving their annual mine plans,\" CEO Bradford Cooke says.</li><li>EXK notes the El Compas mine achieved commercial production in mid-March but only contributed two weeks of production during Q1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450068\" data-linked=\"Endeavour Silver -5% as Q1 production falls sharply\" data-tweet=\"$EXK - Endeavour Silver -5% as Q1 production falls sharply https://seekingalpha.com/news/3450068-endeavour-silverminus-5-q1-production-falls-sharply?source=tweet\" data-url=\"https://seekingalpha.com/news/3450068-endeavour-silverminus-5-q1-production-falls-sharply\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450056\" data-ts=\"1554998603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GDDY\" target=\"_blank\">GDDY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450056-godaddyplus-3_7-on-marketplaces-launch-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GoDaddy +3.7% on Marketplaces launch, acquisition</a></h4><ul><li>GoDaddy (NYSE:<a href='https://seekingalpha.com/symbol/GDDY' title='GoDaddy Inc.'>GDDY</a>) <font color=\"green\">gains 3.7%</font> after <a href=\"https://seekingalpha.com/pr/17473217-entrepreneurs-can-now-easily-sell-everywhere-launch-godaddy-marketplaces\" target=\"_blank\">launching </a>Marketplaces, which lets customers easily list online store inventory through Amazon, eBay, Etsy, Jet, and Walmart.com.</li><li>Sellers can connect to up to three marketplaces and process up to 50 orders per month for free or upgrade to a paid plan.</li><li>The company also announces acquiring multi-channel management platform Sellbrite, which is powering Marketplaces. Financial terms weren't disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450056\" data-linked=\"GoDaddy +3.7% on Marketplaces launch, acquisition\" data-tweet=\"$GDDY - GoDaddy +3.7% on Marketplaces launch, acquisition https://seekingalpha.com/news/3450056-godaddyplus-3_7-on-marketplaces-launch-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3450056-godaddyplus-3_7-on-marketplaces-launch-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450055\" data-ts=\"1554998475\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450055-westport-fuel-systems-and-alkaline-water-company-among-consumer-gainers-vince-holding-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Westport Fuel Systems and Alkaline Water Company among consumer gainers; Vince Holding and Youngevity International among losers</a></h4><ul><li><b>Gainers: </b>The Alkaline Water Company (NASDAQ:<a href='https://seekingalpha.com/symbol/WTER' title='The Alkaline Water Company Inc.'>WTER</a>) <font color=\"green\">+8%</font>. CCA Industries (NYSEMKT:<a href='https://seekingalpha.com/symbol/CAW' title='CCA Industries, Inc.'>CAW</a>) <font color=\"green\">+6%</font>. Westport Fuel Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems Inc.'>WPRT</a>) <font color=\"green\">+6%</font>. Ballantyne Strong (NYSEMKT:<a href='https://seekingalpha.com/symbol/BTN' title='Ballantyne Strong, Inc'>BTN</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Farmmi (NASDAQ:<a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi, Inc.'>FAMI</a>) <font color=\"red\">-40%</font>. Vince Holding (NYSE:<a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a>) <font color=\"red\">-7%</font>. Youngevity International (NASDAQ:<a href='https://seekingalpha.com/symbol/YGYI' title='Youngevity International, Inc.'>YGYI</a>) <font color=\"red\">-5%</font>. Village Farms International (NASDAQ:<a href='https://seekingalpha.com/symbol/VFF' title='Village Farms International, Inc.'>VFF</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450055\" data-linked=\"Westport Fuel Systems and Alkaline Water Company among consumer gainers; Vince Holding and Youngevity International among losers\" data-tweet=\"$WTER $CAW $WPRT - Westport Fuel Systems and Alkaline Water Company among consumer gainers; Vince Holding and Youngevity International among losers https://seekingalpha.com/news/3450055-westport-fuel-systems-and-alkaline-water-company-among-consumer-gainers-vince-holding-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3450055-westport-fuel-systems-and-alkaline-water-company-among-consumer-gainers-vince-holding-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450053\" data-ts=\"1554998362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STNG\" target=\"_blank\">STNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450053-scorpio-tankersplus-8-b-riley-fbr-adds-to-alpha-generator-list\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scorpio Tankers +8% as B. Riley FBR adds to Alpha Generator List</a></h4><ul><li>Scorpio Tankers (<a href='https://seekingalpha.com/symbol/STNG' title='Scorpio Tankers Inc.'>STNG</a> <font color=\"green\">+8%</font>) surges to a YTD high as B. Riley FBR cities an improving and stabilizing macro environment for product tankers and the company's \"solid positioning\" in the sector.</li><li>In <a href=\"https://thefly.com/thestreet/realmoney/index.php/STNGid2891111/STNG-Scorpio-Tankers-added-to-Alpha-Generator-list-at-B-Riley-FBR\" target=\"_blank\">adding the stock to its Alpha Generator List</a>, the firm says STNG should benefit from the underlying strength in product tanker markets driven by the declining pace of new shipbuilding and the increase in demand for distillates to meet the IMO 2020 standards.</li><li>B. Riley says STNG is well positioned for steadily increasing time charter equivalents to drive strong operating leverage and free cash flow, with potential upside based on the improving health of product tanker markets.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450053\" data-linked=\"Scorpio Tankers +8% as B. Riley FBR adds to Alpha Generator List\" data-tweet=\"$STNG - Scorpio Tankers +8% as B. Riley FBR adds to Alpha Generator List https://seekingalpha.com/news/3450053-scorpio-tankersplus-8-b-riley-fbr-adds-to-alpha-generator-list?source=tweet\" data-url=\"https://seekingalpha.com/news/3450053-scorpio-tankersplus-8-b-riley-fbr-adds-to-alpha-generator-list\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450042\" data-ts=\"1554997231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450042-new-all-time-high-for-lvmh-after-strong-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New all-time high for LVMH after strong quarter</a></h4><ul> <li>LVMH Moët Hennessy - Louis Vuitton (<a href='https://seekingalpha.com/symbol/LVMHF' title='LVMH Moët Hennessy - Louis Vuitton, Société Européenne'>OTCPK:LVMHF</a>) races to a new all-time high in European trading after the company posted strong Q1 sales.</li> <li>Revenue was up 16% to \u20ac12.5B during the quarter and like-for-like sales were 11% higher.</li> <li>LVMH says the trends observed in 2018 continued throughout the first quarter, with all geographic regions experiencing good growth.</li><li>\"Revenue growth at Fashion &amp; Leather, the stock\u2019s key sentiment driver, was above even the highest estimates,\" noted BAML's Ashley Wallace about the Q1 print.</li> <li>Within the high-end apparel sector, Kering SA (<a href='https://seekingalpha.com/symbol/PPRUF' title='Kering SA'>OTCPK:PPRUF</a>, <a href='https://seekingalpha.com/symbol/PPRUY' title='Kering SA'>OTCPK:PPRUY</a>) <font color=\"green\">gained 2.29%</font> and Richemont (<a href='https://seekingalpha.com/symbol/CFRHF' title='Compagnie Financière Richemont SA'>OTCPK:CFRHF</a>, <a href='https://seekingalpha.com/symbol/CFRUY' title='Compagnie Financière Richemont SA'>OTCPK:CFRUY</a>) was <font color=\"green\">up 1.85%</font>.</li> <li><a href=\"https://www.lvmh.com/news-documents/press-releases/revenue-growth-of-16-in-first-quarter-2019/\" target=\"_blank\">LVMH press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3450042\" data-linked=\"New all-time high for LVMH after strong quarter\" data-tweet=\"$LVMHF $PPRUF $PPRUY - New all-time high for LVMH after strong quarter https://seekingalpha.com/news/3450042-new-all-time-high-for-lvmh-after-strong-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3450042-new-all-time-high-for-lvmh-after-strong-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450039\" data-ts=\"1554996569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGC\" target=\"_blank\">CGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450039-cannabis-names-under-pressure-on-scotia-negativity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cannabis names under pressure on Scotia negativity</a></h4><ul><li>Expect a big earnings miss for Canopy Growth (<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a> <font color='red'>-3.5%</font>), says Scotia, <a href=\"https://twitter.com/markflowchatter/status/1116356607867260928\" target=\"_blank\">slashing its</a> revenue estimate for FQ4 by 26% to $87M.</li><li>Details are slim, <a href=\"https://www.streetinsider.com/Analyst+Comments/Scotiabank+Says+Expectations+for+Cannabis+Names+are+Too+Optimistic+%28CGC%29+%28TLRY%29+%28ACB%29/15361659.html\" target=\"_blank\">but Scotia is noting</a> over-optimistic expectations for a number of cannabis players, including Tilray (<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color='red'>-3%</font>), and Aurora Cannabis (<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a> <font color='red'>-2%</font>).</li><li>Related ETFs: <a href='https://seekingalpha.com/symbol/MJ' title='ETFMG Alternative Harvest ETF'>MJ</a>, <a href='https://seekingalpha.com/symbol/SOIL' title='Global X Fertilizers/Potash ETF'>SOIL</a>, <a href='https://seekingalpha.com/symbol/ACT' title='AdvisorShares Vice ETF'>ACT</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3450039\" data-linked=\"Cannabis names under pressure on Scotia negativity\" data-tweet=\"$CGC $TLRY $ACB - Cannabis names under pressure on Scotia negativity https://seekingalpha.com/news/3450039-cannabis-names-under-pressure-on-scotia-negativity?source=tweet\" data-url=\"https://seekingalpha.com/news/3450039-cannabis-names-under-pressure-on-scotia-negativity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>105&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450038\" data-ts=\"1554996540\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKEP\" target=\"_blank\">BKEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450038-blueknight-energy-names-andeavors-woodward-new-cfo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blueknight Energy names Andeavor&#39;s Woodward as new CFO</a></h4><ul><li>Andeavor Logistics (<a href='https://seekingalpha.com/symbol/ANDX' title='Andeavor Logistics LP'>ANDX</a> <font color='red'>-0.3%</font>) executive Andrew Woodward will become the <a href=\"https://seekingalpha.com/pr/17473875-blueknight-energy-partners-l-p-names-new-cfo\" target=\"_blank\">new CFO</a> at Blueknight Energy Partners (<a href='https://seekingalpha.com/symbol/BKEP' title='Blueknight Energy Partners, L.P.'>BKEP</a> <font color='green'>+2%</font>), effective April 29.</li><li>Woodward became ANDX's VP of Finance and Treasurer last October after serving as senior director of Finance and Investor Relations; he joined ANDX in 2015 after serving as VP of midstream at RBC Capital Markets.</li><li>Chief Accounting Officer James Griffin was filling in as acting CFO following last year's resignation of Alex Stallings.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450038\" data-linked=\"Blueknight Energy names Andeavor&#39;s Woodward as new CFO\" data-tweet=\"$BKEP $ANDX $BKEP - Blueknight Energy names Andeavor&#39;s Woodward as new CFO https://seekingalpha.com/news/3450038-blueknight-energy-names-andeavors-woodward-new-cfo?source=tweet\" data-url=\"https://seekingalpha.com/news/3450038-blueknight-energy-names-andeavors-woodward-new-cfo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450033\" data-ts=\"1554995809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENTA\" target=\"_blank\">ENTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450033-data-on-enantas-hbv-and-nash-candidates-fail-to-lift-shares-down-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Data on Enanta&#39;s HBV and NASH candidates fail to lift shares, down 2%</a></h4><ul><li>Thinly traded Enanta Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ENTA' title='Enanta Pharmaceuticals, Inc.'>ENTA</a> <font color=\"red\">-2.2%</font>) is down on light volume following its announcement of <a href=\"https://seekingalpha.com/pr/17474169-enanta-pharmaceuticals-presents-new-preclinical-data-compounds-targeting-hepatitis-b-virus\" target=\"_blank\">preclinical data</a> on its wholly owned programs in HBV and NASH. The results are being presented at The International Liver Congress in Vienna.</li><li>EDP-514: In a mouse model, the HBV core inhibitor demonstrated pan-genotypic activity and combining it with other antiretroviral therapies may have synergistic effects. A Phase 1 study should launch in H2.</li><li>NASH: In a rat model, Enanta compounds EP-026856 and EDP-305 and Gilead's selonsertib were evaluated. All three inhibited fibrosis development but EP-026856 showed the greatest effect on returning non-invasive serum markers back to baseline. Preliminary data from the Phase 2 ARGON-1 study assessing EDP-305 in NASH should be available in Q3.</li><li>In a mouse model of liver injury and metabolic disease, EP-027315, an ASK-1 inhibitor, demonstrated a liver protective effect in a diet-induced obesity model. Suppression of markers of liver injury, inflammation and apoptotic pathways were also observed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450033\" data-linked=\"Data on Enanta&#39;s HBV and NASH candidates fail to lift shares, down 2%\" data-tweet=\"$ENTA - Data on Enanta&#39;s HBV and NASH candidates fail to lift shares, down 2% https://seekingalpha.com/news/3450033-data-on-enantas-hbv-and-nash-candidates-fail-to-lift-shares-down-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3450033-data-on-enantas-hbv-and-nash-candidates-fail-to-lift-shares-down-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450030\" data-ts=\"1554995581\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PXLW\" target=\"_blank\">PXLW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450030-pixelworks-and-youku-announce-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pixelworks and YOUKU announce agreement</a></h4><ul><li>Pixelworks (<a href='https://seekingalpha.com/symbol/PXLW' title='Pixelworks, Inc.'>PXLW</a> <font color='green'>+5.3%</font>) and YOUKU <a href=\"https://seekingalpha.com/pr/17473143-pixelworks-youku-announce-agreement-bring-high-quality-hdr-video-ecosystem-mobile-devices\" target=\"_blank\">announced</a> a multi-year marketing and license agreement to jointly advance the ecosystem for HDR format video on mobile devices in China.</li><li>Under the agreement, YOUKU will utilize the Pixelworks TrueCut platform to remaster existing titles in HDR and also create new titles for its growing subscriber base of over 500M users.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450030\" data-linked=\"Pixelworks and YOUKU announce agreement\" data-tweet=\"$PXLW - Pixelworks and YOUKU announce agreement https://seekingalpha.com/news/3450030-pixelworks-and-youku-announce-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3450030-pixelworks-and-youku-announce-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450028\" data-ts=\"1554995327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBAY\" target=\"_blank\">EBAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450028-soft-data-report-dings-ebay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Soft data report dings eBay</a></h4><ul> <li>Shares of eBay (NASDAQ:<a href='https://seekingalpha.com/symbol/EBAY' title='eBay Inc.'>EBAY</a>) are <font color=\"red\">down 3.25%</font> after data from YipitData shows a deceleration in the e-commerce platform's U.S. marketplaces business for Q1, per Bloomberg.</li> <li>YipitData says it provides information for over 150 hedge funds and long-only asset managers.</li> <li>Even with today's decline, eBay trades up 30% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3450028\" data-linked=\"Soft data report dings eBay\" data-tweet=\"$EBAY - Soft data report dings eBay https://seekingalpha.com/news/3450028-soft-data-report-dings-ebay?source=tweet\" data-url=\"https://seekingalpha.com/news/3450028-soft-data-report-dings-ebay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450024\" data-ts=\"1554995029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450024-acer-therapeutics-and-evofem-biosciences-among-healthcare-gainers-intercept-pharmaceuticals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acer Therapeutics and Evofem Biosciences among healthcare gainers; Intercept Pharmaceuticals leads the losers</a></h4><ul><li><b>Gainers: </b>Evofem Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/EVFM' title='Evofem Biosciences, Inc.'>EVFM</a>) <font color=\"green\">+22%</font>. Immuron (NASDAQ:<a href='https://seekingalpha.com/symbol/IMRN' title='Immuron Limited'>IMRN</a>) <font color=\"green\">+13%</font>. Hancock Jaffe Laboratories (NASDAQ:<a href='https://seekingalpha.com/symbol/HJLI' title='Hancock Jaffe Laboratories, Inc.'>HJLI</a>) <font color=\"green\">+12%</font>. Acer Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ACER' title='Acer Therapeutics Inc.'>ACER</a>) <font color=\"green\">+11%</font>. NantKwest (NASDAQ:<a href='https://seekingalpha.com/symbol/NK' title='NantKwest, Inc.'>NK</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>Intercept Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals, Inc.'>ICPT</a>) <font color=\"red\">-13%</font>. Outlook Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a>) <font color=\"red\">-12%</font>. Millendo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MLND' title='Millendo Therapeutics, Inc.'>MLND</a>) <font color=\"red\">-10%</font>. Catabasis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CATB' title='Catabasis Pharmaceuticals, Inc.'>CATB</a>) <font color=\"red\">-9%</font>. Quorum Health (NYSE:<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450024\" data-linked=\"Acer Therapeutics and Evofem Biosciences among healthcare gainers; Intercept Pharmaceuticals leads the losers\" data-tweet=\"$EVFM $IMRN $HJLI - Acer Therapeutics and Evofem Biosciences among healthcare gainers; Intercept Pharmaceuticals leads the losers https://seekingalpha.com/news/3450024-acer-therapeutics-and-evofem-biosciences-among-healthcare-gainers-intercept-pharmaceuticals?source=tweet\" data-url=\"https://seekingalpha.com/news/3450024-acer-therapeutics-and-evofem-biosciences-among-healthcare-gainers-intercept-pharmaceuticals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450021\" data-ts=\"1554994595\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAD\" target=\"_blank\">RAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450021-rite-aid-to-sell-cbd-products-pull-e-cigs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rite Aid to sell CBD products, pull e-cigs</a></h4><ul> <li>Rite Aid (NYSE:<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a>) says it will start selling CBD products in more than 200 stores in Oregon and Washington later this month.</li> <li>The drugstore chain plans to offer CBD creams, lotions and lip balm at the locations.</li> <li>During today's earnings call, Rite Aid COO Bryan Everett said the company would stop selling e-cigarettes amid the crackdown on teenage usage, but continue to sell cigarettes.</li> <li>Rite Aid is <font color=\"red\">down 13.0%</font> on the day, swapping hands at a new 52-week low of $0.49 earlier in the session. Shares are down 71% over the last 52 weeks.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449996-soft-guidance-sends-rite-aid-6-percent\" target=\"_blank\">Soft guidance sends Rite Aid down 6%</a> (April 11)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3450021\" data-linked=\"Rite Aid to sell CBD products, pull e-cigs\" data-tweet=\"$RAD - Rite Aid to sell CBD products, pull e-cigs https://seekingalpha.com/news/3450021-rite-aid-to-sell-cbd-products-pull-e-cigs?source=tweet\" data-url=\"https://seekingalpha.com/news/3450021-rite-aid-to-sell-cbd-products-pull-e-cigs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450018\" data-ts=\"1554993837\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450018-baml-sizes-up-department-store-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML sizes up department store sector</a></h4><ul> <li>Bank of America Merrill Lynch says its aggregated credit and debit card data suggests that department store sales were up 1.7% Y/Y in March.</li> <li>\"We attribute the improvement to a turn in weather and a catch up in tax refunds, partly offset by the build up to Easter shifting from March to April,\" notes the BAML analyst team.</li> <li>\"Better trends in March is consistent with commentary from Macy\u2019s at our consumer conference that trends had stabilized in early March once refunds had caught up and the government shutdown was further in the rear view. Department store shoppers tend to be highly weather sensitive, especially at the lower-end. We remain cautious on the department stores as macro tailwinds abate.\"</li> <li>BAML has Underperform ratings on Macy's (<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s, Inc.'>M</a> <font color='red'>-0.5%</font>), J.C. Penney (<a href='https://seekingalpha.com/symbol/JCP' title='J. C. Penney Company, Inc.'>JCP</a> <font color='red'>-1.2%</font>), Dillard's (<a href='https://seekingalpha.com/symbol/DDS' title='Dillard&#39;s, Inc.'>DDS</a> <font color='red'>-0.5%</font>) and Nordstrom (<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom, Inc.'>JWN</a> <font color='red'>-1.2%</font>). The exception to the firm's cautious stance is Kohl's (<a href='https://seekingalpha.com/symbol/KSS' title='Kohl&#39;s Corporation'>KSS</a> <font color='red'>-1.2%</font>), which is reiterated at Buy on the expectation for strong revenue and EPS growth.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450018\" data-linked=\"BAML sizes up department store sector\" data-tweet=\"$M $JCP $DDS - BAML sizes up department store sector https://seekingalpha.com/news/3450018-baml-sizes-up-department-store-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3450018-baml-sizes-up-department-store-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450016\" data-ts=\"1554993405\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450016-pg-and-e-in-talks-bluemountain-for-new-board-appointments-reports-say\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E in talks with BlueMountain for new board appointments, reports say</a></h4><ul><li>PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='green'>+2.4%</font>) is talking with shareholder BlueMountain Capital about <a href=\"https://finance.yahoo.com/news/pg-e-discuss-board-appointments-220953528.html\" target=\"_blank\">potentially changing some of the board nominees</a> the company <a href=\"https://seekingalpha.com/news/3448288-pg-and-e-appoints-tvas-johnson-next-ceo-announces-new-board-slate\" target=\"_blank\">announced last week</a>, according to multiple reports.</li><li>BlueMountain, which owns a 2.5% stake in PG&amp;E, had nominated its own directors who were passed over in favor of a slate of 10 new directors organized in partnership with another group of investors.</li><li>PG&amp;E reportedly has been <a href=\"https://www.reuters.com/article/us-pg-e-us-bluemountain/pge-in-talks-with-bluemountain-to-possibly-expand-board-sources-idUSKCN1RM2XH\" target=\"_blank\">impressed with the skill set</a> the BlueMountain nominees bring in three main areas - doing business in California, safety and risk management, and utility and clean energy operations - and hopes further changes could address concerns expressed by California Gov. Newsom that last week's board appointments lacked the necessary expertise.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450016\" data-linked=\"PG&amp;E in talks with BlueMountain for new board appointments, reports say\" data-tweet=\"$PCG - PG&amp;E in talks with BlueMountain for new board appointments, reports say https://seekingalpha.com/news/3450016-pg-and-e-in-talks-bluemountain-for-new-board-appointments-reports-say?source=tweet\" data-url=\"https://seekingalpha.com/news/3450016-pg-and-e-in-talks-bluemountain-for-new-board-appointments-reports-say\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450013\" data-ts=\"1554993056\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNG\" target=\"_blank\">UNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450013-natural-gas-inventory-builds-slightly-less-expected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory builds slightly less than expected</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory</a>: <b>+25</b> <strong>Bcf</strong> vs. +29 Bcf consensus, -23 Bcf last week.</li><li>Futures <font color=\"red\">-0.56%</font> to $2.685.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3450013\" data-linked=\"Natural gas inventory builds slightly less than expected\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory builds slightly less than expected https://seekingalpha.com/news/3450013-natural-gas-inventory-builds-slightly-less-expected?source=tweet\" data-url=\"https://seekingalpha.com/news/3450013-natural-gas-inventory-builds-slightly-less-expected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450009\" data-ts=\"1554992487\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVFM\" target=\"_blank\">EVFM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450009-evofem-up-13-on-bullish-80m-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evofem up 13% on bullish $80M capital raise</a></h4><ul><li>Thinly traded micro cap Evofem Biosciences (<a href='https://seekingalpha.com/symbol/EVFM' title='Evofem Biosciences, Inc.'>EVFM</a> <font color=\"green\">+13.2%</font>) is up on modestly higher volume, albeit on turnover of only 25K shares, in apparent response to its <a href=\"https://www.ft.com/content/cd00ad30-5bdb-11e9-939a-341f5ada9d40\" target=\"_blank\">$80M capital raise</a> that it will use to push birth control gel Amphora over the finish line and prepare for commercial launch.</li><li>PDL Biopharma (<a href='https://seekingalpha.com/symbol/PDLI' title='PDL BioPharma, Inc.'>PDLI</a>) will lead the <a href=\"https://seekingalpha.com/pr/17474182-evofem-biosciences-enters-financing-agreement-80-million-closes-first-tranche-strategic\" target=\"_blank\">private round</a>, buying $60M of newly issued EVFM common shares at $4.50, a 20% premium over the current price of $3.75.</li><li>EVFM stockholders Woodford Investment Management and Invesco Asset Management have the option to invest up to $10M each at the same price.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450009\" data-linked=\"Evofem up 13% on bullish $80M capital raise\" data-tweet=\"$EVFM $PDLI - Evofem up 13% on bullish $80M capital raise https://seekingalpha.com/news/3450009-evofem-up-13-on-bullish-80m-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3450009-evofem-up-13-on-bullish-80m-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450006\" data-ts=\"1554992367\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450006-pizza-m-delivered-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pizza M&amp;A delivered up</a></h4><ul> <li>There's a little bit of movement in pizza stocks on a down market day after Papa Murphy's (<a href='https://seekingalpha.com/symbol/FRSH' title='Papa Murphy&#39;s Holdings, Inc.'>FRSH</a> <font color='green'>+31.2%</font>) attracts a buyout offer from Canadian franchise specialist MTY Food Group.</li> <li>Rave Restaurant Group (NASDAQ:<a href='https://seekingalpha.com/symbol/RAVE' title='RAVE Restaurant Group, Inc.'>RAVE</a>) is up <font color=\"green\">2.45%</font>, Domino's Pizza (NYSE:<a href='https://seekingalpha.com/symbol/DPZ' title='Domino&#39;s Pizza, Inc.'>DPZ</a>) is <font color=\"green\">2.22%</font> higher and Papa John's International (NASDAQ:<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a>) is showing a <font color=\"green\">0.74%</font> gain. Pizza Hut owner Yum Brands (NYSE:<a href='https://seekingalpha.com/symbol/YUM' title='YUM! Brands, Inc.'>YUM</a>) is up <font color=\"green\">0.24%</font>, although the pizza business ranks third behind tacos and chicken at the restaurant giant.</li> <li>Papa Murphy's trades just a few pennies short of the $6.42 deal price</li> <li>Papa Murphy's joins Panini Pizza and Pizza Delight as pizza brands owned by MTY.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449914-papa-murphys-plus-31-percent-taking-buyout-deal\" target=\"_blank\">Papa Murphy's +31% after taking buyout deal</a> (April 11)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3450006\" data-linked=\"Pizza M&amp;A delivered up\" data-tweet=\"$FRSH $RAVE $DPZ - Pizza M&amp;A delivered up https://seekingalpha.com/news/3450006-pizza-m-delivered-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3450006-pizza-m-delivered-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3450001\" data-ts=\"1554991731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DSGX\" target=\"_blank\">DSGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3450001-descartesminus-2_9-on-cibc-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Descartes -2.9% on CIBC downgrade</a></h4><ul><li>CIBC bank cuts Descartes (NASDAQ:<a href='https://seekingalpha.com/symbol/DSGX' title='The Descartes Systems Group Inc'>DSGX</a>) from Outperform to Neutral citing valuation and slowing trade volumes.</li><li>PT stays at $41.</li><li>Descartes shares are <font color=\"red\">down 2.9%</font> to $37.83.</li></ul><div class=\"tiny-share-widget\" data-id=\"3450001\" data-linked=\"Descartes -2.9% on CIBC downgrade\" data-tweet=\"$DSGX - Descartes -2.9% on CIBC downgrade https://seekingalpha.com/news/3450001-descartesminus-2_9-on-cibc-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3450001-descartesminus-2_9-on-cibc-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449996\" data-ts=\"1554991485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAD\" target=\"_blank\">RAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449996-soft-guidance-sends-rite-aid-down-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Soft guidance sends Rite Aid down 6%</a></h4><ul> <li>Rite Aid (NYSE:<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a>) is <font color=\"red\">down 6.11%</font> in morning trading after a Q4 revenue shortfall and soft guidance.</li> <li>The drugstore operator expects full-year revenue of $21.5B to $21.9B vs. $22.2B consensus, full-year EBITDA of $500M to $560M vs. $566M consensus and EPS of -$0.01 to $0.04 vs. $0.02 consensus.</li> <li>Management's update on the FY20: \"The company\u2019s outlook for fiscal 2020 assumes a decline in reimbursement rates consistent with the decline experienced in fiscal 2019. However, based upon conditions in the generic drug market, the company does not expect to be able to as effectively offset these declines with generic drug purchasing savings as in the prior year. The company\u2019s outlook also assumes a reduction of approximately $40 million in TSA fee income from WBA, which the company expects to offset by the reduction in corporate SG&amp;A costs that was disclosed last month. The Company also has factored into the outlook an increase in rent expense of $11 million as a result of the adoption of the new lease accounting standard.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449887-rite-aid-beats-0_02-misses-revenue\" target=\"_blank\">Rite Aid beats by $0.02, misses on revenue</a> (April 11)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449996\" data-linked=\"Soft guidance sends Rite Aid down 6%\" data-tweet=\"$RAD - Soft guidance sends Rite Aid down 6% https://seekingalpha.com/news/3449996-soft-guidance-sends-rite-aid-down-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3449996-soft-guidance-sends-rite-aid-down-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>90&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449990\" data-ts=\"1554990691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVH\" target=\"_blank\">EVH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449990-evolent-up-10-on-rosier-prospects-for-largest-customer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evolent up 10% on rosier prospects for largest customer</a></h4><ul><li>Evolent Health (<a href='https://seekingalpha.com/symbol/EVH' title='Evolent Health, Inc.'>EVH</a> <font color=\"green\">+10.3%</font>) is up in early trade in apparent response to a healthier outlook for a Kentucky non-profit called Passport, its largest customer, representing about 10 - 12% of its revenues.</li><li>Passport has apparently won a rate increase in the state's Medicaid rates that should shore up its finances and enable it to remain solvent.</li><li>SVB Leerink's David Larsen says the rate increase should stoke a revenue jump for EVH in H2, adding that there may be additional upside with specialty care management services.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449990\" data-linked=\"Evolent up 10% on rosier prospects for largest customer\" data-tweet=\"$EVH - Evolent up 10% on rosier prospects for largest customer https://seekingalpha.com/news/3449990-evolent-up-10-on-rosier-prospects-for-largest-customer?source=tweet\" data-url=\"https://seekingalpha.com/news/3449990-evolent-up-10-on-rosier-prospects-for-largest-customer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449986\" data-ts=\"1554990261\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FBHS\" target=\"_blank\">FBHS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449986-china-risk-seen-for-fortune-brands-home-security\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China risk seen for Fortune Brands Home &amp; Security</a></h4><ul> <li>Fortune Brands Home &amp; Security (NYSE:<a href='https://seekingalpha.com/symbol/FBHS' title='Fortune Brands Home & Security, Inc.'>FBHS</a>) is <font color=\"red\">down 1.82%</font> after Barclays turns negative on the home and security products seller.</li> <li>Analyst Matthew Bouley and team think Fortune Brands Home &amp; Security is at risk of losing sales to China.</li><li>The firm lowers Fortune Brands Home &amp; Security to an Underweight rating from Equal-weight.</li> <li>The Barclays cut arrives with shares of FBHS up 28% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449986\" data-linked=\"China risk seen for Fortune Brands Home &amp; Security\" data-tweet=\"$FBHS - China risk seen for Fortune Brands Home &amp; Security https://seekingalpha.com/news/3449986-china-risk-seen-for-fortune-brands-home-security?source=tweet\" data-url=\"https://seekingalpha.com/news/3449986-china-risk-seen-for-fortune-brands-home-security\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449979\" data-ts=\"1554989876\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APOG\" target=\"_blank\">APOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449979-apogee-enterprises-down-9-post-q4-earnings-miss-provides-fy20-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apogee Enterprises down 9% post Q4 earnings miss; provides FY20 guidance</a></h4><ul><li>Apogee Enterprises (<a href='https://seekingalpha.com/symbol/APOG' title='Apogee Enterprises, Inc.'>APOG</a> <font color=\"red\">-9.8%</font>) reported Q4 revenue decline of 2% Y/Y to $346.3M, due to severe winter weather, that caused disruptions at some of the manufacturing locations.</li><li>Sales by Segments: Architectural Framing Systems $170.34M (-7% Y/Y); Architectural Glass $103.67M (+13% Y/Y); Architectural Services $66.26M (-2% Y/Y); and Large-Scale Optical $23.97M (+2% Y/Y).</li><li>Architectural Services segment backlog increased to $444M during the quarter, from $419.2M last quarter and $426.3M a year ago.</li><li>Q4 Gross margin <font color=\"red\">fell by 1,145 bps</font> to 12.8%; operating margin <font color=\"red\">declined by 1,215 bps</font> to -4.3%; and Adj. operating margin <font color=\"red\">declined by 60 bps</font> to 9%.</li><li>Q4 Adj. EBITDA decreased by 8.3% Y/Y to $42.38M; and margin <font color=\"red\">declined by 84 bps</font> to 12.2%.</li><li>SG&amp;A expenses were $59.06M up by 2% Y/Y; and as percentage of revenue 17.1% up by 60 bps.</li><li>Net cash provided by operating activities YTD was $96.42M, compared to $127.46M a year ago.</li><li><strong>FY20 Guidance</strong>: Revenue growth 1% to 3%; EPS $3 to $3.2; Operating margin between 8.2 to 8.6%; Tax rate of ~24.5%; and Capital expenditures of $60M to $65M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449878-apogee-misses-0_06-misses-revenue\" target=\"_blank\">Apogee misses by $0.06, misses on revenue</a> (April 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3449979\" data-linked=\"Apogee Enterprises down 9% post Q4 earnings miss; provides FY20 guidance\" data-tweet=\"$APOG - Apogee Enterprises down 9% post Q4 earnings miss; provides FY20 guidance https://seekingalpha.com/news/3449979-apogee-enterprises-down-9-post-q4-earnings-miss-provides-fy20-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3449979-apogee-enterprises-down-9-post-q4-earnings-miss-provides-fy20-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449984\" data-ts=\"1554989810\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRAY\" target=\"_blank\">VRAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449984-viewray-touts-study-supporting-efficacy-of-mridian\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ViewRay touts study supporting efficacy of MRIdian</a></h4><ul><li>ViewRay (<a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay, Inc.'>VRAY</a> <font color=\"green\">+0.5%</font>) is up out the gate this morning on the heels of a just-published retrospective <a href=\"https://seekingalpha.com/pr/17473702-viewray-announces-publication-retrospective-study-mr-guided-radiation-treatment-locally\" target=\"_blank\">analysis </a>of the outcomes of MRI-guided radiation therapy delivered with its MRIdian system in patients with locally advanced pancreatic cancer. The study appears in this month's edition of <em>Cancer Medicine.</em></li><li>Pooled data on 44 patients showed a 49% survival rate at year 2 in the high-dose group compared to 30% in the low-dose group. No patients receiving high-dose treatment experienced serious or life-threatening acute toxicity versus 7% in the low-dose group.</li><li>CEO Scott Drake says, \"These data suggest that MRIdian-guided adaptive radiotherapy may help survival while greatly reducing toxicity rates. We are pleased to support the prospective study of this promising finding and thank the multi-institutional teams for their work to improve patient care and outcomes.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3449984\" data-linked=\"ViewRay touts study supporting efficacy of MRIdian\" data-tweet=\"$VRAY - ViewRay touts study supporting efficacy of MRIdian https://seekingalpha.com/news/3449984-viewray-touts-study-supporting-efficacy-of-mridian?source=tweet\" data-url=\"https://seekingalpha.com/news/3449984-viewray-touts-study-supporting-efficacy-of-mridian\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449981\" data-ts=\"1554989561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTSI\" target=\"_blank\">MTSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449981-macomminus-5_5-on-cfo-resignation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MACOM -5.5% on CFO resignation</a></h4><ul><li>MACOM (NASDAQ:<a href='https://seekingalpha.com/symbol/MTSI' title='MACOM Technology Solutions Holdings, Inc.'>MTSI</a>) <a href=\"https://seekingalpha.com/pr/17474013-macom-announces-departure-robert-j-mcmullan-chief-financial-officer\" target=\"_blank\">announces</a> Robert McMullan has submitted his resignation for personal reasons. He will transition to an advisory role and support the transition for the next two months.</li><li>The company appoints Conor Hegarty, VP of Financial Planning and Analysis, to the role of principal financial officer and principal accounting officer, effective immediately.</li><li>MACOM shares are <font color=\"red\">down 5.5%</font> to $17.21.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449981\" data-linked=\"MACOM -5.5% on CFO resignation\" data-tweet=\"$MTSI - MACOM -5.5% on CFO resignation https://seekingalpha.com/news/3449981-macomminus-5_5-on-cfo-resignation?source=tweet\" data-url=\"https://seekingalpha.com/news/3449981-macomminus-5_5-on-cfo-resignation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449973\" data-ts=\"1554988921\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASMB\" target=\"_blank\">ASMB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449973-assembly-bio-down-3-premarket-on-next-gen-core-protein-inhibitor-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Assembly Bio down 3% premarket on next-gen core protein inhibitor data</a></h4><ul><li>Thinly traded Assembly Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ASMB' title='Assembly Biosciences, Inc.'>ASMB</a>) is down <font color=\"red\">3% </font>premarket on light volume in response to <a href=\"https://seekingalpha.com/pr/17473514-assembly-biosciences-presents-data-highlighting-next-generation-hbv-core-protein-inhibitors\" target=\"_blank\">new data</a> on its next-generation core protein inhibitors ABI-H2158 and ABI-H3733. The results are being presented at The International Liver Congress in Vienna.</li><li>ABI-H2158: Phase 1a data in healthy volunteers showed a favorable safety profile with expected trough liver exposures above the threshold for the establishment of covalently closed circular DNA (cccDNA) (special DNA structure that arises during the propagation of certain viruses) with once-daily administration. A Phase 1b study has been initiated in patients with chronic HBV infection.</li><li>ABI-H3733: Preclinical data showed potent inhibitory activity against multiple steps in the HBV infection cycle, especially those related to cccDNA generation.</li><li>Data from a cccDNA turnover study suggests that therapies inhibiting the establishment of new cccDNA may lead to higher cure rates for HBV infection.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449973\" data-linked=\"Assembly Bio down 3% premarket on next-gen core protein inhibitor data\" data-tweet=\"$ASMB - Assembly Bio down 3% premarket on next-gen core protein inhibitor data https://seekingalpha.com/news/3449973-assembly-bio-down-3-premarket-on-next-gen-core-protein-inhibitor-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3449973-assembly-bio-down-3-premarket-on-next-gen-core-protein-inhibitor-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449969\" data-ts=\"1554988451\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449969-caesars-entertainmentplus-3-merger-talk-swirls\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caesars Entertainment +3% as merger talk swirls</a></h4><ul> <li>Shares of Caesars Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment Corporation'>CZR</a>) are <font color=\"green\">up 2.65%</font> in premarket trading after sources tip the <em>New York Post</em> that the casino company is going to announce the approval of a sales process very oon.</li> <li>Adding to the intrigue, Tilman Fertitta and Eldorado Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/ERI' title='Eldorado Resorts, Inc.'>ERI</a>) have both taken a look at Caesars' financial records, according to the report.</li> <li>Last month, Macquarie highlighted the upside from a Caesars-Eldorado combination, pointing to a $10 to $14 takeout price on CZR. The 52-week high for Caesars is $13.54.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449849-caesars-expected-formalize-sales-process-week\" target=\"_blank\">Caesars expected to formalize sales process this week</a> (April 10)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449969\" data-linked=\"Caesars Entertainment +3% as merger talk swirls\" data-tweet=\"$CZR $ERI - Caesars Entertainment +3% as merger talk swirls https://seekingalpha.com/news/3449969-caesars-entertainmentplus-3-merger-talk-swirls?source=tweet\" data-url=\"https://seekingalpha.com/news/3449969-caesars-entertainmentplus-3-merger-talk-swirls\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449968\" data-ts=\"1554988395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449968-vktx-frsh-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VKTX, FRSH among premarket gainers</a></h4><ul><li>China Bat (NASDAQ:<a href='https://seekingalpha.com/symbol/GLG' title='China Bat Group, Inc.'>GLG</a>) <font color=\"green\">+45%</font> on <a href=\"https://seekingalpha.com/pr/17473180-china-bat-group-inc-enters-strategic-cooperation-agreement-liten-group-co-ltd\" target=\"_blank\">entering</a> into a strategic cooperation agreement with Liten Group.</li><li>Papa Murphy's Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/FRSH' title='Papa Murphy&#39;s Holdings, Inc.'>FRSH</a>) <font color=\"green\">+31%</font> after taking buyout <a href=\"https://seekingalpha.com/news/3449914-papa-murphys-plus-31-percent-taking-buyout-deal\" target=\"_blank\">deal</a>.</li><li>Hancock Jaffe Laboratories (NASDAQ:<a href='https://seekingalpha.com/symbol/HJLI' title='Hancock Jaffe Laboratories, Inc.'>HJLI</a>) <font color=\"green\">+22%</font> on <a href=\"https://seekingalpha.com/pr/17473804-hancock-jaffe-successfully-completes-four-venovalve-implantations-first-human-study\" target=\"_blank\">successfully</a> implanting VenoValves in four additional patients for its first-in-human study in Bogota, Colombia.</li><li>Viking Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics, Inc.'>VKTX</a>) <font color=\"green\">+8%</font> on new VK2809 <a href=\"https://seekingalpha.com/news/3449927-viking-ahead-7-percent-premarket-new-vk2809-data\" target=\"_blank\">data</a>.</li><li>ToughBuilt (NASDAQ:<a href='https://seekingalpha.com/symbol/TBLT' title='ToughBuilt Industries, Inc.'>TBLT</a>) <font color=\"green\">+10% </font>on <a href=\"https://seekingalpha.com/pr/17473985-toughbuilt-announces-agreement-canadian-third-party-logistics-wholesale-services-company\" target=\"_blank\">entering</a> into a sales and marketing agreement with Bull Sales.</li><li>Evolent Health (NYSE:<a href='https://seekingalpha.com/symbol/EVH' title='Evolent Health, Inc.'>EVH</a>) <font color=\"green\">+7%</font>.</li><li>Motif Bio plc (NASDAQ:<a href='https://seekingalpha.com/symbol/MTFB' title='Motif Bio plc'>MTFB</a>) <font color=\"green\">+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449968\" data-linked=\"VKTX, FRSH among premarket gainers\" data-tweet=\"$GLG $FRSH $HJLI - VKTX, FRSH among premarket gainers https://seekingalpha.com/news/3449968-vktx-frsh-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3449968-vktx-frsh-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449967\" data-ts=\"1554988349\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449967-bbby-and-icpt-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BBBY and ICPT among premarket losers</a></h4><ul><li>ATA (NASDAQ:<a href='https://seekingalpha.com/symbol/ATAI' title='ATA Inc.'>ATAI</a>) <font color=\"red\">-21%</font>.</li><li>Marathon Patent Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>) <font color=\"red\">-14%</font>.</li><li>Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) <font color=\"red\">-11%</font> on <a href=\"https://seekingalpha.com/news/3449794-bed-bath-and-beyond-beats-0_10-misses-revenue\" target=\"_blank\">Q4 results</a>.</li><li>Apogee Enterprises (NASDAQ:<a href='https://seekingalpha.com/symbol/APOG' title='Apogee Enterprises, Inc.'>APOG</a>) <font color=\"red\">-9%</font> on <a href=\"https://seekingalpha.com/news/3449878-apogee-misses-0_06-misses-revenue\" target=\"_blank\">Q4 results</a>.</li><li>Intercept Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals, Inc.'>ICPT</a>) <font color=\"red\">-9%</font> on <a href=\"https://seekingalpha.com/news/3449915-intercept-reports-additional-data-late-stage-study-oca-nash\" target=\"_blank\">reporting</a> additional data from late-stage study of OCA in NASH.</li><li>Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"red\">-8%</font>.</li><li>Weight Watchers International (NASDAQ:<a href='https://seekingalpha.com/symbol/WTW' title='Weight Watchers International, Inc.'>WTW</a>) <font color=\"red\">-7%</font> on JPMorgan <a href=\"https://seekingalpha.com/news/3449960-ww-minus-6-percent-jpmorgan-gloom\" target=\"_blank\">gloom</a>.</li><li>Second Sight Medical Products (NASDAQ:<a href='https://seekingalpha.com/symbol/EYES' title='Second Sight Medical Products, Inc.'>EYES</a>) <font color=\"red\">-6%</font> on updated <a href=\"https://seekingalpha.com/news/3449945-second-sight-11-percent-premarket-updated-orion-data\" target=\"_blank\">Orion data</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449967\" data-linked=\"BBBY and ICPT among premarket losers\" data-tweet=\"$AACG $MARA $BBBY - BBBY and ICPT among premarket losers https://seekingalpha.com/news/3449967-bbby-and-icpt-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3449967-bbby-and-icpt-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449964\" data-ts=\"1554987980\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WM\" target=\"_blank\">WM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449964-waste-stocks-downgraded-stifel-seeing-recycling-headwinds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Waste stocks downgraded by Stifel, seeing recycling headwinds</a></h4><ul><li>Waste Management (NYSE:<a href='https://seekingalpha.com/symbol/WM' title='Waste Management, Inc.'>WM</a>) <font color=\"red\">-1.8%</font> pre-market after Stifel <a href=\"https://www.streetinsider.com/Analyst+Comments/Stifel+Downgrades+Waste+Management+%28WM%29+to+Hold/15360870.html\" target=\"_blank\">downgrades</a> the stock - as well as peers Waste Connections (NYSE:<a href='https://seekingalpha.com/symbol/WCN' title='Waste Connections, Inc.'>WCN</a>), Advanced Disposal Services (NYSE:<a href='https://seekingalpha.com/symbol/ADSW' title='Advanced Disposal Services, Inc.'>ADSW</a>) and Republic Services (NYSE:<a href='https://seekingalpha.com/symbol/RSG' title='Republic Services, Inc.'>RSG</a>) - to Hold from Buy, saying the recycling business has deteriorated more than expected.</li><li>YTD recycled paper prices are down $34/ton from the FY 2018 average, and paper accounts for 60%-70% of the recycling basket for most  companies, which translates into ~$20/ton of headwind, Stifel analyst Michael Hoffman says.</li><li>The demand is there, but new low contamination restrictions in other  importing countries such as Vietnam, India and Indonesia are disrupting the flow  of goods, and paper prices are falling again, Hoffman says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449964\" data-linked=\"Waste stocks downgraded by Stifel, seeing recycling headwinds\" data-tweet=\"$WM $WCN $ADSW - Waste stocks downgraded by Stifel, seeing recycling headwinds https://seekingalpha.com/news/3449964-waste-stocks-downgraded-stifel-seeing-recycling-headwinds?source=tweet\" data-url=\"https://seekingalpha.com/news/3449964-waste-stocks-downgraded-stifel-seeing-recycling-headwinds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449963\" data-ts=\"1554987961\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OBLN\" target=\"_blank\">OBLN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449963-obalon-to-explore-strategic-alternatives-shares-up-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Obalon to explore strategic alternatives; shares up 4% premarket</a></h4><ul> <li>Obalon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OBLN' title='Obalon Therapeutics, Inc.'>OBLN</a>) has <a href=\"https://seekingalpha.com/pr/17473643-obalon-engages-cowen-explore-financial-strategic-alternatives\" target=\"_blank\">retained</a> Cowen as an financial advisor to assist it in exploring financial and strategic alternatives.</li><li>The company recently initiated a restructuring aimed at reducing costs.</li><li>Shares are up <font color=\"green\">4%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3448098-obalon-cut-half-workforce-restructuring-shares-21-percent\" target=\"_blank\">Obalon to cut half of workforce in restructuring; shares down 21%</a> (April 3)</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3449963\" data-linked=\"Obalon to explore strategic alternatives; shares up 4% premarket\" data-tweet=\"$OBLN - Obalon to explore strategic alternatives; shares up 4% premarket https://seekingalpha.com/news/3449963-obalon-to-explore-strategic-alternatives-shares-up-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3449963-obalon-to-explore-strategic-alternatives-shares-up-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449962\" data-ts=\"1554987947\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOP\" target=\"_blank\">SHOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449962-shopify-boosted-on-strong-q1-checks-roth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shopify boosted on strong Q1 checks - Roth</a></h4><ul><li>Roth maintains a Buy rating on Shopify (NYSE:<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify Inc.'>SHOP</a>) and raises the PT from $200 to $225 citing channel checks showing continued health in Q1 that suggest another strong quarter.</li><li>Rating remains at Buy.</li><li>Shopify is expected to report earnings on May 7. Analysts <a href=\"https://seekingalpha.com/symbol/SHOP/earnings\" target=\"_blank\">estimate</a> $310.08M in revenue with a $0.05 loss per share.</li><li>Shopify shares are <font color=\"green\">up 0.5%</font> pre-market to $207.42.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449962\" data-linked=\"Shopify boosted on strong Q1 checks - Roth\" data-tweet=\"$SHOP - Shopify boosted on strong Q1 checks - Roth https://seekingalpha.com/news/3449962-shopify-boosted-on-strong-q1-checks-roth?source=tweet\" data-url=\"https://seekingalpha.com/news/3449962-shopify-boosted-on-strong-q1-checks-roth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449960\" data-ts=\"1554987779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WTW\" target=\"_blank\">WTW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449960-wwminus-6-on-jpmorgan-gloom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WW -6% on more JPMorgan gloom</a></h4><ul> <li>JPMorgan lowers estimates on WW (NASDAQ:<a href='https://seekingalpha.com/symbol/WTW' title='Weight Watchers International, Inc.'>WTW</a>) after taking in recent data that showed a 40% Y/Y drop in daily average users for WW subscribers during Q1.</li> <li>Also in the mix, JP says WW may be forced to make prepayment on a portion of its $1.5B term loan due to exceeding its covenant leverage target.</li> <li>JP keeps an Underweight rating on WTW and slides its price target to $12 from $14. The new PT implies a drop in WW of about 40%.</li> <li>Shares of WW are down 47% YTD. In the premarket session, WW is <font color=\"red\">off 6.05%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449960\" data-linked=\"WW -6% on more JPMorgan gloom\" data-tweet=\"$WTW $WW - WW -6% on more JPMorgan gloom https://seekingalpha.com/news/3449960-wwminus-6-on-jpmorgan-gloom?source=tweet\" data-url=\"https://seekingalpha.com/news/3449960-wwminus-6-on-jpmorgan-gloom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449953\" data-ts=\"1554987322\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVS\" target=\"_blank\">CVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449953-stifel-neutral-on-incyte-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel neutral on Incyte in premarket analyst action</a></h4><ul><li>CVS Health (NYSE:<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a>) initiated with Market Perform rating and $58 (8% upside) price target at BMO. Share down a fraction premarket.</li><li>Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) initiated with Hold rating and $82 (2% downside risk) price target at Stifel.</li><li>PTC Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics, Inc.'>PTCT</a>) initiated with Outperform rating and $48 (24% upside) price target at Bernstein.</li><li>Seattle Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGEN' title='Seattle Genetics, Inc.'>SGEN</a>) initiated with Hold rating and $70 (13% downside risk) price target at Stifel.</li><li>AmerisourceBergen (NYSE:<a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a>) initiated with Buy rating at Guggenheim.</li><li>ArQule (NASDAQ:<a href='https://seekingalpha.com/symbol/ARQL' title='ArQule, Inc.'>ARQL</a>) initiated with Outperform rating and $9 (59% upside) price target at RBC.</li><li>Cardiovascular Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CSII' title='Cardiovascular Systems, Inc.'>CSII</a>) downgraded to Underperform with a $42 (10% downside risk) price target. Shares down <font color=\"red\">3% </font>premarket.</li><li>Eli Lilly (NYSE:<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>) downgraded to Neutral with a $127 (flat) price target at Guggenheim citing valuation and limited upside.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449953\" data-linked=\"Stifel neutral on Incyte in premarket analyst action\" data-tweet=\"$CVS $INCY $PTCT - Stifel neutral on Incyte in premarket analyst action https://seekingalpha.com/news/3449953-stifel-neutral-on-incyte-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3449953-stifel-neutral-on-incyte-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449946\" data-ts=\"1554986853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRED\" target=\"_blank\">FRED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449946-fredsplus-4-after-strategic-review-launched\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fred&#39;s +4% after strategic review launched</a></h4><ul><li>Fred's (NASDAQ:<a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a>) announces that it will evaluate strategic alternatives to maximize value for shareholders. Financial advisory firm PJ Solomon was hired to help Fred's in the process.</li><li>The retailer has already decided to close underperforming and unprofitable stores following a comprehensive evaluation of the store portfolio. Liquidation sales efforts at the 159 stores currently designated for closure are beginning today.</li>    <li>CEO update: \"After a careful review, we have made the decision to rationalize our footprint by closing underperforming stores, with a particular focus on locations with shorter duration leases.  Most of these stores have near-term lease expirations and limited remaining lease obligations.\"</li><li>Shares of Fred's are <font color=\"green\">up 3.88%</font> in premarket action.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17473815-fred-s-retains-pj-solomon-evaluate-strategic-alternatives-maximize-value\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3449946\" data-linked=\"Fred&#39;s +4% after strategic review launched\" data-tweet=\"$FRED - Fred&#39;s +4% after strategic review launched https://seekingalpha.com/news/3449946-fredsplus-4-after-strategic-review-launched?source=tweet\" data-url=\"https://seekingalpha.com/news/3449946-fredsplus-4-after-strategic-review-launched\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449945\" data-ts=\"1554986616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYES\" target=\"_blank\">EYES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449945-second-sight-down-11-premarket-on-updated-orion-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Second Sight down 11% premarket on updated Orion data</a></h4><ul><li>Thinly traded micro cap Second Sight Medical Products (NASDAQ:<a href='https://seekingalpha.com/symbol/EYES' title='Second Sight Medical Products, Inc.'>EYES</a>) slips <font color=\"red\">11%</font> premarket on increased volume in reaction to its <a href=\"https://seekingalpha.com/pr/17473669-second-sight-medical-products-inc-presents-positive-interim-results-fifth-annual-brain\" target=\"_blank\">update </a>on its early feasibility study of the Orion Visual Prosthesis System designed to create an artificial form of useful vision for the blind. The results are being presented today at the BRAIN Initiative Investigators Meeting in Washington, DC.</li><li>A total of six subjects have been implanted since January 2018.</li><li>At month six, three of five patients were able to locate a high-contrast target with ORION turned on versus when it was off (measured by Square Localization), but only two of five were able to determine the direction of motion of the high-contrast target with ORION on versus off.</li><li>On the safety front, one serious adverse event &#40;AE&#41; (seizure) and four non-serious AEs have been reported as of February 8, 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449945\" data-linked=\"Second Sight down 11% premarket on updated Orion data\" data-tweet=\"$EYES - Second Sight down 11% premarket on updated Orion data https://seekingalpha.com/news/3449945-second-sight-down-11-premarket-on-updated-orion-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3449945-second-sight-down-11-premarket-on-updated-orion-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449937\" data-ts=\"1554985853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIVE\" target=\"_blank\">FIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449937-five-belowplus-4-on-jpmorgan-confidence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Five Below +4% on JPMorgan confidence</a></h4><ul> <li>JPMorgan believes there is \"high visibility\" on Five Below's (NASDAQ:<a href='https://seekingalpha.com/symbol/FIVE' title='Five Below, Inc.'>FIVE</a>) path to 20% annual revenue growth.</li> <li>The firm points to high-teens unit growth for Five Below and low-single-digit core comps in adding up to the 20% mark.</li> <li>Shares of FIVE are bumped up to Overweight and assigned a price target of $150 (40X JP's 2020 EPS estimate).</li> <li>Five Below is <font color=\"green\">up 3.74%</font> in premarket action to $134.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449937\" data-linked=\"Five Below +4% on JPMorgan confidence\" data-tweet=\"$FIVE - Five Below +4% on JPMorgan confidence https://seekingalpha.com/news/3449937-five-belowplus-4-on-jpmorgan-confidence?source=tweet\" data-url=\"https://seekingalpha.com/news/3449937-five-belowplus-4-on-jpmorgan-confidence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449936\" data-ts=\"1554985819\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVID\" target=\"_blank\">AVID</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449936-avidminus-1_5-on-cash-tender-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avid -1.5% on cash tender offer</a></h4><ul><li>Avid (NASDAQ:<a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a>) <a href=\"https://seekingalpha.com/pr/17473735-avid-technology-announces-cash-tender-offer-2_00-percent-senior-convertible-notes-due-2020\" target=\"_blank\">commences</a> an offer for any and all of its 2% senior convertible notes due 2020. There are currently about $102.9M in notes outstanding.</li><li>To facilitate the repurchase, Avid amends its existing credit facility to include a new $100M delayed draw term loan commitment and reduce its interest rate from LIBOR +667 to LIBOR +625.</li><li>Avid shares are <font color=\"red\">down 1.5%</font> pre-market to $8.49.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449936\" data-linked=\"Avid -1.5% on cash tender offer\" data-tweet=\"$AVID - Avid -1.5% on cash tender offer https://seekingalpha.com/news/3449936-avidminus-1_5-on-cash-tender-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3449936-avidminus-1_5-on-cash-tender-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449929\" data-ts=\"1554984722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KDP\" target=\"_blank\">KDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449929-keurig-dr-pepperminus-4-after-morgan-stanley-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Keurig Dr Pepper -4% after Morgan Stanley cut</a></h4><ul> <li>Morgan Stanley drops Keurig Dr Pepper (NYSE:<a href='https://seekingalpha.com/symbol/KDP' title='Keurig Dr Pepper Inc.'>KDP</a>) to an Underweight rating from Equal-weight after finding downside in coffee system sales relative to high market expectations.</li> <li>\"Our ~80 bps below consensus corporate revenue forecast is supported by takeaways from our survey in terms of slowing household penetration and further pressure in pod pricing. From a valuation standpoint, a high valuation bar (~17x NTM EV/EBITDA) and our below-consensus estimates create a -2.3:1.0 negatively skewed risk-reward,\" warns MS.</li> <li>The firm takes its price target on the beverage stock to $24 from $27 due to the lower coffee estimates.</li> <li>Shares of KDP are <font color=\"red\">down 3.78%</font> premarket to $27.00 vs. the 52-week trading range of $18.92 to $28.81.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449929\" data-linked=\"Keurig Dr Pepper -4% after Morgan Stanley cut\" data-tweet=\"$KDP - Keurig Dr Pepper -4% after Morgan Stanley cut https://seekingalpha.com/news/3449929-keurig-dr-pepperminus-4-after-morgan-stanley-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3449929-keurig-dr-pepperminus-4-after-morgan-stanley-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449927\" data-ts=\"1554984664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VKTX\" target=\"_blank\">VKTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449927-viking-ahead-7-premarket-on-new-vk2809-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viking ahead 7% premarket on new VK2809 data</a></h4><ul><li>Viking Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics, Inc.'>VKTX</a>) is up <font color=\"green\">7%</font> premarket on average volume in reaction to <a href=\"https://seekingalpha.com/pr/17473508-viking-therapeutics-presents-new-data-phase-2-study-vk2809-patients-non-alcoholic-fatty-liver\" target=\"_blank\">additional data</a> from its <a href=\"https://clinicaltrials.gov/ct2/show/NCT02927184?term=vk2809&amp;rank=1\" target=\"_blank\">12-week Phase 2 clinical trial</a> evaluating thyroid beta agonist VK2809 in patients with nonalcoholic fatty liver disease &#40;NAFLD&#41; and elevated low-density lipoprotein cholesterol (LDL-C, also known as the \"bad\" cholesterol). The results are being presented at The International Liver Congress in Vienna.</li><li>The trial met the primary endpoint of statistically significant reductions in LDL-C at week 12 in treated patients compared to placebo. Patients receiving VK2809 also showed statistically valid improvements in other lipids.</li><li>100% of patients who received 5 mg of VK2809 once per day were considered responders (at least a 30% relative reduction in liver fat at week 12). The response rates in the 10 mg once-daily arm and the 10 mg once every other day arm were 90.9% and 76.9%, respectively, well above 16.7% in the placebo group. The median reduction in liver fat in the 5 mg arm was 53.8%.</li><li>The safety profile of the 5 mg dose was similar to 10 mg. No serious adverse events were reported.</li><li>Related ticker: Madrigal Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3449927\" data-linked=\"Viking ahead 7% premarket on new VK2809 data\" data-tweet=\"$VKTX $MDGL - Viking ahead 7% premarket on new VK2809 data https://seekingalpha.com/news/3449927-viking-ahead-7-premarket-on-new-vk2809-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3449927-viking-ahead-7-premarket-on-new-vk2809-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449926\" data-ts=\"1554984414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449926-jefferies-cools-on-chipotle-due-to-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies cools on Chipotle due to valuation</a></h4><ul> <li>Jefferies lowers Chipotle (NYSE:<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a>) to a Hold rating from Buy.</li> <li>\"With CMG stock up +65% (vs +13% S&amp;P) in 1Q, we believe valuation is full and reflects improved visibility for powerful SSS and margin drivers,\" writes the firm.</li> <li>Jefferies is still positive on the restaurant chain's momentum, noting drivers related to digital/delivery, loyalty and marketing should keep same-store sales strong.</li> <li>Chipotle is assigned a price target of $700 by Jefferies.</li> <li>Shares of CMG are <font color=\"red\">down 1.19%</font> premarket to $710.30.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449926\" data-linked=\"Jefferies cools on Chipotle due to valuation\" data-tweet=\"$CMG - Jefferies cools on Chipotle due to valuation https://seekingalpha.com/news/3449926-jefferies-cools-on-chipotle-due-to-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3449926-jefferies-cools-on-chipotle-due-to-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449925\" data-ts=\"1554984382\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449925-u-s-steel-sinks-baml-double-downgrades-steelmageddon-victim\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel sinks as BAML double downgrades &#39;Steelmageddon victim&#39;</a></h4><ul><li>U.S. Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>) <font color=\"red\">-3.3%</font> pre-market after Bank of America Merrill Lynch <a href=\"https://www.streetinsider.com/Analyst+Comments/BofAMerrill+Lynch+Downgrades+US+Steel+%28X%29+to+Underperform%2C+PT+Slashed+to+%2418/15361360.html\" target=\"_blank\">double downgrades</a> shares to Underperform from Buy with an $18 price target, cut from $31.</li><li>U.S. Steel is the latest \"Steelmageddon victim,\" says BAML analyst Timna Tanners, as U.S. market conditions are worse than expected.</li><li>\"Not only have recent price hikes not stuck but benchmark hot rolled coil retreated to its lows of the year in recent days,\" Tanners writes, adding that U.S. mills have been pricing sheet at or below landed import prices.</li><li>U.S. Steel is \"burning cash,\" Tanners warns, expecting the company will burn through as much as $200M during 2019-21, and recent damage at a blast furnace may compound the company\u2019s problems.</li><li>The stock also was downgraded at Credit Suisse <a href=\"https://seekingalpha.com/news/3449220-u-s-steel-downgraded-credit-suisse-weaker-competitive-position\" target=\"_blank\">earlier this week</a>, saying the company was \"in a weaker competitive position\" relative to its peers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449925\" data-linked=\"U.S. Steel sinks as BAML double downgrades &#39;Steelmageddon victim&#39;\" data-tweet=\"$X - U.S. Steel sinks as BAML double downgrades &#39;Steelmageddon victim&#39; https://seekingalpha.com/news/3449925-u-s-steel-sinks-baml-double-downgrades-steelmageddon-victim?source=tweet\" data-url=\"https://seekingalpha.com/news/3449925-u-s-steel-sinks-baml-double-downgrades-steelmageddon-victim\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449915\" data-ts=\"1554983177\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICPT\" target=\"_blank\">ICPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449915-intercept-reports-additional-data-from-late-stage-study-of-oca-in-nash\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intercept reports additional data from late-stage study of OCA in NASH</a></h4><ul><li>Intercept Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals, Inc.'>ICPT</a>) <a href=\"https://seekingalpha.com/pr/17473309-intercept-reports-additional-positive-data-regenerate-first-successful-phase-3-study-nash\" target=\"_blank\">announces</a> more data from the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02548351?titles=regenerate&amp;lead=intercept+pharmaceuticals&amp;phase=2&amp;rank=1\" target=\"_blank\">REGENERATE</a> clinical trial evaluating obeticholic acid &#40;OCA&#41; in NASH patients with liver fibrosis. The results are being presented at The International Liver Congress in Vienna.</li><li>As <a href=\"https://seekingalpha.com/news/3434349-intercept-23-percent-premarket-positive-oca-data\" target=\"_blank\">reported </a>in February, REGENERATE met one co-primary endpoint (a statistically significant proportion of patients achieving at least a one-stage improvement in fibrosis with no worsening of NASH at month 18) but failed to meet the other (a statistically significant proportion of patients achieving NASH resolution with no worsening of liver fibrosis). Per FDA agreement, only one needed to be met for study success.</li><li>Additional analyses based on the per-protocol population (n=668) showed that 13.3% patients receiving 25 mg of OCA each day for at least 15 months experienced at least a two-stage improvement in fibrosis compared to 4.5% for placebo (p=0.0008).</li><li>In patients who experienced at least a one-stage change in fibrosis, 38.0% of those receiving OCA 25 mg once-daily improved versus 13.1% who worsened. In the control group, 23.2% improved compared to 20.9% who worsened. 65.6% of treated patients (OCA 25 mg) with elevated ALT (enzyme biomarker of liver stress/damage) at baseline achieved normal levels compared to 37.3% for placebo. The proportions of patients with elevations in another liver enzyme, AST, who achieved normal levels were 54.7% for OCA and 29.3% for control.</li><li>On the safety front, adverse events (AEs) were mainly mild or moderate. The rates of serious AEs were 14% in the OCA 25 mg arm, 11% in the OCA 10 mg arm and 11% in the control arm. There were three deaths (two in the control arm and one (glioblastoma) in the OCA 25 mg arm), none considered treatment-related. 3% of patients in the OCA 25 mg arm experienced gallstones or gallbladder inflammation (cholecystitis) compared to 1% in the OCA 10 arm and less then 1% in the control arm. The company says there was no pattern attributable to OCA.</li><li>The company will host a conference call today at 11:45 am ET to discuss the results.</li><li>Shares are down <font color=\"red\">1%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449915\" data-linked=\"Intercept reports additional data from late-stage study of OCA in NASH\" data-tweet=\"$ICPT - Intercept reports additional data from late-stage study of OCA in NASH https://seekingalpha.com/news/3449915-intercept-reports-additional-data-from-late-stage-study-of-oca-in-nash?source=tweet\" data-url=\"https://seekingalpha.com/news/3449915-intercept-reports-additional-data-from-late-stage-study-of-oca-in-nash\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449914\" data-ts=\"1554983132\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRSH\" target=\"_blank\">FRSH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449914-papa-murphysplus-31-after-taking-buyout-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Papa Murphy&#39;s +31% after taking buyout deal</a></h4><ul> <li>MTY Food Group acquires Papa Murphy's (NASDAQ:<a href='https://seekingalpha.com/symbol/FRSH' title='Papa Murphy&#39;s Holdings, Inc.'>FRSH</a>) for $190M, including the company's outstanding deal.</li><li>The deal was struck at $6.45 per share.</li><li>The terms and conditions of the merger agreement were unanimously approved by the boards of directors of both companies.</li><li>Shares of Papa Murphy's are <font color=\"green\">up 30.88%</font> premarket to $6.40.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17473489-mty-food-group-inc-papa-murphy-s-holdings-inc-announce-definitive-merger-agreement\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3449914\" data-linked=\"Papa Murphy&#39;s +31% after taking buyout deal\" data-tweet=\"$FRSH - Papa Murphy&#39;s +31% after taking buyout deal https://seekingalpha.com/news/3449914-papa-murphysplus-31-after-taking-buyout-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3449914-papa-murphysplus-31-after-taking-buyout-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449907\" data-ts=\"1554982183\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449907-lyft-faces-bumpy-ride-hsbc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lyft faces &#39;bumpy ride&#39; - HSBC</a></h4><ul><li>HSBC initiates Lyft (NASDAQ:<a href='https://seekingalpha.com/symbol/LYFT' title='Lyft, Inc.'>LYFT</a>) at Hold with a $60 PT saying the company is likely to have a \"bumpy ride\" with near-term competitive intensity from Uber (<a href='https://seekingalpha.com/symbol/UBER' title='Uber'>UBER</a>) that could remain fierce.</li><li>The firm says self-driving vehicles could prove a \"game changer\" but doesn't expect this to happen before 2025.</li><li>Lyft shares are <font color=\"green\">up 1.2%</font> pre-market after closing yesterday <font color=\"red\">down 10.9%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449513-uber-seeks-10b-years-biggest-ipo\" target=\"_blank\">Uber seeks about $10B in year's biggest IPO</a> (April 10)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449751-uber-seeks-conservative-100b-public-valuation-wsj\" target=\"_blank\">Uber seeks conservative $100B public valuation - WSJ</a> (April 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3449907\" data-linked=\"Lyft faces &#39;bumpy ride&#39; - HSBC\" data-tweet=\"$LYFT $UBER - Lyft faces &#39;bumpy ride&#39; - HSBC https://seekingalpha.com/news/3449907-lyft-faces-bumpy-ride-hsbc?source=tweet\" data-url=\"https://seekingalpha.com/news/3449907-lyft-faces-bumpy-ride-hsbc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449899\" data-ts=\"1554981708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FAST\" target=\"_blank\">FAST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449899-fastenal-inches-up-after-eps-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fastenal inches up after EPS beat</a></h4><ul><li>Diluted net earnings per share were $0.68 vs. $0.61 during the first quarter of 2018, an increase of 11.9%.</li><li>Daily sales of fastener products grew 11.1%. Sales of non-fastener products represented 65.2% of sales and grew 12.7% on a daily basis.</li><li>Signed 5,603 industrial vending devices, resulting in an installed device count of 83,410, an increase of 13.4% over March 31, 2018.</li><li>Fastenal also signed 105 new Onsite locations in Q1, resulting in 945 active sites on March 31, 2019, representing an increase of 39.4% from a year ago.</li><li><a href='https://seekingalpha.com/symbol/FAST' title='Fastenal Company'>FAST</a> <font color=\"green\">+0.2%</font> premarket</li><li><a href=\"https://seekingalpha.com/news/3449882-fastenal-beats-0_01-revenue-line\" target=\"_blank\">Q1 results</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3449899\" data-linked=\"Fastenal inches up after EPS beat\" data-tweet=\"$FAST - Fastenal inches up after EPS beat https://seekingalpha.com/news/3449899-fastenal-inches-up-after-eps-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3449899-fastenal-inches-up-after-eps-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449887\" data-ts=\"1554980516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAD\" target=\"_blank\">RAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449887-rite-aid-beats-0_02-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rite Aid beats by $0.02, misses on revenue</a></h4><ul><li>Rite Aid (NYSE:<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a>): Q4 Non-GAAP EPS of -$0.01 <span style=\"color:green\">beats by $0.02</span>; GAAP EPS of -$0.24.</li><li>Revenue of $5.38B (-0.2% Y/Y) <font color=\"red\">misses by $180M</font>.</li><li>Shares <font color=\"green\">+5.69%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17473457-rite-aid-reports-fiscal-2019-fourth-quarter-full-year-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3449887\" data-linked=\"Rite Aid beats by $0.02, misses on revenue\" data-tweet=\"$RAD - Rite Aid beats by $0.02, misses on revenue https://seekingalpha.com/news/3449887-rite-aid-beats-0_02-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3449887-rite-aid-beats-0_02-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}